WO2014160402A1 - Co-conversion de glucides en produits de fermentation dans une étape de fermentation unique - Google Patents

Co-conversion de glucides en produits de fermentation dans une étape de fermentation unique Download PDF

Info

Publication number
WO2014160402A1
WO2014160402A1 PCT/US2014/026499 US2014026499W WO2014160402A1 WO 2014160402 A1 WO2014160402 A1 WO 2014160402A1 US 2014026499 W US2014026499 W US 2014026499W WO 2014160402 A1 WO2014160402 A1 WO 2014160402A1
Authority
WO
WIPO (PCT)
Prior art keywords
sugar
straw
microorganisms
fermentation
ethanol
Prior art date
Application number
PCT/US2014/026499
Other languages
English (en)
Inventor
Lee R. Lynd
Justin D. VAN ROOYEN
Original Assignee
Mascoma Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mascoma Corporation filed Critical Mascoma Corporation
Publication of WO2014160402A1 publication Critical patent/WO2014160402A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/06Ethanol, i.e. non-beverage
    • C12P7/08Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate
    • C12P7/10Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate substrate containing cellulosic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/54Acetic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/56Lactic acid
    • DTEXTILES; PAPER
    • D21PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21CPRODUCTION OF CELLULOSE BY REMOVING NON-CELLULOSE SUBSTANCES FROM CELLULOSE-CONTAINING MATERIALS; REGENERATION OF PULPING LIQUORS; APPARATUS THEREFOR
    • D21C5/00Other processes for obtaining cellulose, e.g. cooking cotton linters ; Processes characterised by the choice of cellulose-containing starting materials
    • D21C5/005Treatment of cellulose-containing material with microorganisms or enzymes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Definitions

  • ethanol and other fermentation products are produced from various foodstuffs such as sugar (e.g. , derived from either sugar cane or sugar beet and starch), or derived from sources such as corn, wheat and potato.
  • sugar e.g. , derived from either sugar cane or sugar beet and starch
  • sources such as corn, wheat and potato.
  • biomass lignocellulosic biomass
  • biomass lignocellulosic biomass
  • Biomass is particularly well-suited for energy applications because of its large-scale availability, low cost, and environmentally benign production.
  • many energy production and utilization cycles based on cellulosic biomass have near-zero greenhouse gas emissions on a life-cycle basis.
  • the primary obstacle impeding the more widespread production of energy from biomass feedstocks is the general absence of low- cost technology for overcoming the recalcitrance of these materials to conversion into useful products.
  • Lignocellulosic biomass contains carbohydrate fractions (e.g., cellulose and hemicellulose) that can be converted into ethanol or other products such as lactic acid and acetic acid.
  • carbohydrate fractions e.g., cellulose and hemicellulose
  • the cellulose and hemicellulose must ultimately be converted or hydrolyzed into monosaccharides; it is the hydrolysis that has historically proven to be problematic.
  • biocatalysts have been developed that can liberate carbohydrate from the cellulosic biomass and ferment the resulting carbohydrates into end products using little or no added enzymes.
  • Biomass processing schemes involving enzymatic or microbial hydrolysis commonly involve four biologically mediated transformations: (1) the production of saccharo lytic enzymes (cellulases and hemicellulases); (2) the hydrolysis of carbohydrate components present in pretreated biomass to sugars; (3) the fermentation of hexose sugars (e.g., glucose, mannose, and galactose); and (4) the fermentation of pentose sugars (e.g., xylose and arabinose).
  • saccharo lytic enzymes cellulases and hemicellulases
  • carbohydrate components present in pretreated biomass to sugars
  • hexose sugars e.g., glucose, mannose, and galactose
  • pentose sugars e.g., xylose and arabinose
  • CBP consolidated bioprocessing
  • CBP Consolidated Bio-Processing
  • CBP on plant biomass e.g., lignocellulosic biomass
  • plant biomass e.g., lignocellulosic biomass
  • petrochemical feedstocks to produce fermentable, value added products, such as propanols, alcohols, polyols, and other industrial products.
  • CBP offers the potential for lower cost and higher efficiency than processes featuring dedicated cellulase production.
  • the benefits result in part from avoided capital costs, substrate and other raw materials, and utilities associated with cellulase production.
  • several factors support the realization of higher rates of hydrolysis, and hence reduced reactor volume and capital investment using CBP, including enzyme-microbe synergy and the use of thermophilic organisms and/or complexed cellulase systems.
  • cellulose-adherent cellulolytic microorganisms are likely to compete successfully for products of cellulose hydrolysis with non-adhered microbes, e.g., contaminants, which could increase the stability of industrial processes based on microbial cellulose utilization.
  • CBP CBP
  • the amount of cellulase present is dependent upon synthesis of cellulase within the bioreactor in which cellulose is hydrolyzed and sugars are fermented to products, such as biofuels.
  • CBP performance is quite sensitive to inhibitors and, in particular, often more sensitive to inhibitors than processes in which cellulase is produced separately and added to the reactor in which hydrolysis and/or fermentation occurs.
  • Rates of biomass conversion in a CBP process tend to decrease with increasing biomass concentration, while final ethanol concentration is directly proportional to solids loading. It is desirable to process cellulosic biomass at high solids concentrations because this has the potential to increase the ethanol concentration produced and thus the product production per unit fermentor volume. At the same time, operation at high solids concentration entails challenges and in general the magnitude of these challenges increases disproportionately with increasing solids concentration. Particular challenges include inhibition of cell growth and cellulase synthesis, as well as inhibition of cellulase enzymes - likely both due to higher concentrations of inhibitors. Mixing also becomes more difficult, exacerbating other problems.
  • CBP performs quite well at 12 to 15 wt.% solids, is more difficult at 15 to 20 wt.% solids, and suffers appreciably in the 20 to 25% solids concentrations favored by economics in the absence of performance compromises related to high solids concentration. Rates of conversion can be increased by increasing exogenous enzyme or by boosting the initial yeast innoculum, both of which are costly.
  • the invention is generally directed to a method of co-fermenting a sugar stream(s) with a pretreated lignocellulosic biomass.
  • the invention is directed to a method for the production of a fermentation product, the method comprising: i) contacting a pretreated lignocellulosic biomass feedstock, a sugar stream, and a population of microorganisms capable of hydrolyzing the lignocellulosic biomass and fermenting sugars into a fermentation product; and ii) culturing said population of microorganisms under conditions for a period sufficient to allow hydrolysis of the lignocellulosic biomass and fermentation of sugars by said population of microorganisms into a fermentation product.
  • exogenous enzymes are added to the culture.
  • the lignocellulosic biomass feedstock is selected from the group consisting of: grass, switch grass, cord grass, rye grass, reed canary grass, miscanthus, sugar-processing residues, sugarcane bagasse, agricultural wastes, rice straw, rice hulls, barley straw, corn cobs, cereal straw, wheat straw, canola straw, oat straw, oat hulls, corn fiber, stover, soybean stover, corn stover, forestry wastes, recycled wood pulp fiber, paper sludge, sawdust, hardwood, softwood, Agave, and combinations thereof.
  • the sugar stream is selected from the group consisting of: molasses, sugar cane, sugar beet, corn starch, wheat starch, and potato starch.
  • the sugar stream is provided by a dry milling process. In another embodiment, the sugar stream is provided by a wet milling process.
  • the population of microorganisms is selected from the group consisting of bacteria and yeast.
  • the population of microorganisms comprises at least one genetically modified microorganism.
  • the genetically modified microorganism is a bacterium.
  • the bacterium is thermophilic or mesophilic.
  • the genetically modified microorganism is a fungus.
  • the fungus is a yeast.
  • the fermentation product is selected from the group consisting of an alcohol, lactic acid, and acetic acid.
  • the fermentation product is ethanol.
  • aspects of the present invention relate to a method of co-fermenting sugar stream with a pretreated lignocellulosic biomass.
  • the fermentation method can be located on an existing fermentation facility, such as a corn ethanol mill or a sugarcane ethanol mill.
  • an existing fermentation facility such as a corn ethanol mill or a sugarcane ethanol mill.
  • this will allow for lower higher rates, lower yeast innocula and operation at lower lignocellulosic solids concentrations.
  • reduction in the quantity of food stuff derived carbohydrate will significantly boost profitability of existing fermentation facilities.
  • the term "recombinant host” is intended to include a cell suitable for genetic manipulation, e.g., which can incorporate heterologous polynucleotide sequences, e.g., which can be transfected.
  • the cell can be a microorganism or a higher eukaryotic cell.
  • the term is intended to include progeny of the cell originally transfected.
  • the cell is a fungal cell ⁇ e.g., Saccharomyces cerevisiae) or a bacterial cell ⁇ e.g., a Gram-negative bacterial cell).
  • recombinant hosts are Saccharomyces cerevisiae.
  • recombinant hosts are mesophilic or thermophillic microorganisms, such as thermophilic bacteria including species of Thermoanaeorbacterium ⁇ e.g., T. saccharolyticum) or Clostridium ⁇ e.g., C. thermocellum or C. propionicum).
  • recombinant hosts are Escherichia coli and/or Klebsiella oxytoca cells.
  • Other recombinant host cells include any host cells known in the art or described herein.
  • a "vector,” e.g., a "plasmid” or “YAC” (yeast artificial chromosome) refers to an extrachromosomal element often carrying one or more genes that are not part of the central metabolism of the cell, and is usually in the form of a circular double-stranded DNA molecule.
  • Such elements may be autonomously replicating sequences, genome integrating sequences, phage or nucleotide sequences, linear, circular, or supercoiled, of a single- or double-stranded DNA or RNA, derived from any source, in which a number of nucleotide sequences have been joined or recombined into a unique construction which is capable of introducing a promoter fragment and DNA sequence for a selected gene product along with appropriate 3' untranslated sequence into a cell.
  • the plasmids or vectors of the present invention are stable and self-replicating.
  • An "expression vector” is a vector that is capable of directing the expression of genes to which it is operably associated.
  • heterologous refers to an element of a vector, plasmid or host cell that is derived from a source other than the endogenous source.
  • a heterologous sequence could be a sequence that is derived from a different gene or plasmid from the same host, from a different strain of host cell, or from an organism of a different taxonomic group ⁇ e.g., different kingdom, phylum, class, order, family genus, or species, or any subgroup within one of these classifications).
  • the term “heterologous” is also used synonymously herein with the term “exogenous.”
  • domain refers to a part of a molecule or structure that shares common physical or chemical features, for example hydrophobic, polar, globular, helical domains or properties, e.g., a DNA binding domain or an ATP binding domain. Domains can be identified by their homology to conserved structural or functional motifs. Examples of cellobiohydrolase (CBH) domains include the catalytic domain (CD) and the cellulose binding domain (CBD).
  • CBH cellobiohydrolase
  • nucleic acid is a polymeric compound comprised of covalently linked subunits called nucleotides.
  • Nucleic acid includes polyribonucleic acid (RNA) and polydeoxyribonucleic acid (DNA), both of which may be single-stranded or double-stranded.
  • DNA includes cDNA, genomic DNA, synthetic DNA, and semi-synthetic DNA.
  • isolated nucleic acid molecule refers to the phosphate ester polymeric form of ribonucleosides (adenosine, guanosine, uridine or cytidine; "RNA molecules”) or deoxyribonucleosides (deoxyadenosine, deoxyguanosine, deoxythymidine, or deoxycytidine; "DNA molecules”), or any phosphoester analogs thereof, such as phosphorothioates and thioesters, in either single stranded form, or a double-stranded helix. Double stranded DNA-DNA, DNA-RNA and RNA-RNA helices are possible.
  • nucleic acid molecule refers only to the primary and secondary structure of the molecule, and does not limit it to any particular tertiary forms.
  • this term includes double-stranded DNA found, inter alia, in linear or circular DNA molecules (e.g., restriction fragments), plasmids, and chromosomes.
  • sequences may be described herein according to the normal convention of giving only the sequence in the 5' to 3' direction along the non-transcribed strand of DNA (i.e., the strand having a sequence homologous to the mRNA).
  • a “gene” refers to an assembly of nucleotides that encode a polypeptide, and includes cDNA and genomic DNA nucleic acids. “Gene” also refers to a nucleic acid fragment that expresses a specific protein, including intervening sequences (introns) between individual coding segments (exons), as well as regulatory sequences preceding (5' non-coding sequences) and following (3' non-coding sequences) the coding sequence. “Native gene” refers to a gene as found in nature with its own regulatory sequences.
  • a nucleic acid molecule is "hybridizable" to another nucleic acid molecule, such as a cDNA, genomic DNA, or RNA, when a single stranded form of the nucleic acid molecule can anneal to the other nucleic acid molecule under the appropriate conditions of temperature and solution ionic strength.
  • Hybridization and washing conditions are well known and exemplified, e.g., in Sambrook, J., Fritsch, E. F. and Maniatis, T.
  • One set of conditions uses a series of washes starting with 6X SSC, 0.5% SDS at room temperature for 15 min, then repeated with 2X SSC, 0.5% SDS at 45°C for 30 min, and then repeated twice with 0.2X SSC, 0.5% SDS at 50°C for 30 min.
  • washes are performed at higher temperatures in which the washes are identical to those above except for the temperature of the final two 30 min washes in 0.2X SSC, 0.5%> SDS are increased to 60°C.
  • Another set of highly stringent conditions uses two final washes in
  • 0.1X SSC 0.1% SDS at 65°C.
  • An additional set of highly stringent conditions are defined by hybridization at 0.1X SSC, 0.1% SDS, 65°C and washed with 2X SSC, 0.1% SDS followed by 0. IX SSC, 0.1% SDS.
  • Hybridization requires that the two nucleic acids contain complementary sequences, although depending on the stringency of the hybridization, mismatches between bases are possible.
  • the appropriate stringency for hybridizing nucleic acids depends on the length of the nucleic acids and the degree of complementation, variables well known in the art. The greater the degree of similarity or homology between two nucleotide sequences, the greater the value of Tm for hybrids of nucleic acids having those sequences.
  • the relative stability (corresponding to higher Tm) of nucleic acid hybridizations decreases in the following order: R A:RNA, DNA:RNA, DNA:DNA.
  • equations for calculating Tm have been derived (see, e.g., Maniatis at 9.50-9.51).
  • Tm For hybridizations with shorter nucleic acids,
  • the length for a hybridizable nucleic acid is at least about 10 nucleotides.
  • a minimum length for a hybridizable nucleic acid is at least about 15 nucleotides; more preferably at least about 20 nucleotides; and most preferably the length is at least 30 nucleotides.
  • the temperature and wash solution salt concentration may be adjusted as necessary according to factors such as length of the probe.
  • microorganisms refers to one or more microorganisms, generally in culture.
  • Microorganisms useful in a population of microorganisms includes any host cell, including bacteria or yeast cells, and including recombinant host cells.
  • Non-limiting examples of microorganisms e.g., host cells
  • the population of microorganisms can comprise cells of a single species or a co-culture of cells from different species.
  • heterologous polynucleotide segment is intended to include a polynucleotide segment that encodes one or more polypeptides or portions or fragments of polypeptides.
  • a heterologous polynucleotide segment may be derived from any source, e.g., eukaryotes, prokaryotes, viruses, or synthetic polynucleotide fragments.
  • gene(s) or “polynucleotide segment” or “polynucleotide sequence(s)” are intended to include nucleic acid molecules, e.g., polynucleotides which include an open reading frame encoding a polypeptide, and can further include non-coding regulatory sequences, and introns.
  • the terms are intended to include one or more genes that map to a functional locus.
  • the terms are intended to include a specific gene for a selected purpose.
  • the gene may be endogenous to the host cell or may be recombinantly introduced into the host cell, e.g., as a plasmid maintained episomally or a plasmid (or fragment thereof) that is stably integrated into the genome.
  • a gene may, for example, be in the form of linear DNA.
  • the gene of polynucleotide segment is involved in at least one step in the bioconversion of a carbohydrate to a fermentation product, such as ethanol, acetate, or lactate.
  • the term is intended to include any gene encoding a polypeptide, such as the enzymes acetate kinase (ACK), phosphotransacetylase (PTA), lactate dehydrogenase (LDH), pyruvate formate lyase (PFL), aldehyde dehydrogenase (ADH) and/or alcohol dehydrogenase (ADH), enzymes in the D-xylose pathway, such as xylose isomerase and xylulokinase, enzymes in the L-arabinose pathway, such as L-arabinose isomerase and L-ribulose-5 -phosphate 4-epimerase, a pyruvate decarboxylase, a secretory protein(s), or a polysaccharase, e.g., an endoglucanase, exoglucanase, endoxylanase, exoxylanase, endogalactanase, endoarabin
  • transcriptional control is intended to include the ability to modulate gene expression at the level of transcription.
  • transcription, and thus gene expression is modulated by replacing or adding a surrogate promoter near the 5' end of the coding region of a gene-of-interest, thereby resulting in altered gene expression.
  • the transcriptional control of one or more gene is engineered to result in the optimal expression of such genes, e.g., in a desired ratio.
  • the term also includes inducible transcriptional control as recognized in the art.
  • expression product is intended to include the resultant product, e.g., a polypeptide, of an expressed gene.
  • the term "increased expression” is intended to include an alteration in gene expression at least at the level of increased mRNA production and, preferably, at the level of polypeptide expression.
  • the term “increased production” is intended to include an increase in the amount of a polypeptide expressed, in the level of the enzymatic activity of the polypeptide, or a combination thereof.
  • a DNA or RNA “coding region” is a DNA or RNA molecule which is transcribed and/or translated into a polypeptide in a cell in vitro or in vivo when placed under the control of appropriate regulatory sequences.
  • Suitable regulatory regions refer to nucleic acid regions located upstream (5' non-coding sequences), within, or downstream (3' non- coding sequences) of a coding region, and which influence the transcription, RNA processing or stability, or translation of the associated coding region. Regulatory regions may include promoters, translation leader sequences, RNA processing site, effector binding site and stem-loop structure.
  • a coding region can include, but is not limited to, prokaryotic regions, cDNA from mRNA, genomic DNA molecules, synthetic DNA molecules, or RNA molecules. If the coding region is intended for expression in a eukaryotic cell, a polyadenylation signal and transcription termination sequence will usually be located 3' to the coding region.
  • An "isoform” is a protein that has the same function as another protein but which is encoded by a different gene and may have small differences in its sequence.
  • a "paralogue” is a protein encoded by a gene related by duplication within a genome.
  • orthologue is gene from a different species that has evolved from a common ancestral gene by speciation. Normally, orthologues retain the same function in the course of evolution as the ancestral gene.
  • ORF Open reading frame
  • nucleic acid either DNA, cDNA or RNA, that comprises a translation start signal or initiation codon, such as an ATG or AUG, and a termination codon and can be potentially translated into a polypeptide sequence.
  • Promoter refers to a DNA fragment capable of controlling the expression of a coding sequence or functional RNA.
  • a coding region is located 3' to a promoter. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even comprise synthetic DNA segments. It is understood by those skilled in the art that different promoters may direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental or physiological conditions. Promoters which cause a gene to be expressed in most cell types at most times are commonly referred to as “constitutive promoters”.
  • a promoter is generally bounded at its 3' terminus by the transcription initiation site and extends upstream (5' direction) to include the minimum number of bases or elements necessary to initiate transcription at levels detectable above background. Within the promoter will be found a transcription initiation site (conveniently defined for example, by mapping with nuclease SI), as well as protein binding domains (consensus sequences) responsible for the binding of RNA polymerase.
  • a coding region is "under the control" of transcriptional and translational control elements in a cell when RNA polymerase transcribes the coding region into mRNA, which is then trans-RNA spliced (if the coding region contains introns) and translated into the protein encoded by the coding region.
  • Transcriptional and translational control regions are DNA regulatory regions, such as promoters, enhancers, terminators, and the like, that provide for the expression of a coding region in a host cell.
  • polyadenylation signals are control regions.
  • operably associated refers to the association of nucleic acid sequences on a single nucleic acid fragment so that the function of one is affected by the other.
  • a promoter is operably associated with a coding region when it is capable of affecting the expression of that coding region (i.e., that the coding region is under the transcriptional control of the promoter).
  • Coding regions can be operably associated to regulatory regions in sense or antisense orientation.
  • expression refers to the transcription and stable accumulation of sense (mRNA) or antisense RNA derived from the nucleic acid fragment of the invention. Expression may also refer to translation of mRNA into a polypeptide.
  • activity refers to any functional activity normally attributed to a selected polypeptide when produced under favorable conditions.
  • activity of a selected polypeptide encompasses the total enzymatic activity associated with the produced polypeptide.
  • the polypeptide produced by a host cell and having enzymatic activity may be located in the intracellular space of the cell, cell- associated, secreted into the extracellular milieu, or a combination thereof. Techniques for determining total activity as compared to secreted activity are described herein and are known in the art.
  • xylanolytic activity is intended to include the ability to hydrolyze glycosidic linkages in oligopentoses and polypentoses.
  • cellulolytic activity is intended to include the ability to hydrolyze glycosidic linkages in oligohexoses and polyhexoses. Cellulolytic activity may also include the ability to depolymerize or debranch cellulose and hemicellulose.
  • lactate dehydrogenase or "LDH” is intended to include the enzyme capable of converting pyruvate into lactate. It is understood that LDH can also catalyze the oxidation of hydroxybutyrate.
  • alcohol dehydrogenase or "ADH” is intended to include the enzyme capable of converting acetaldehyde into an alcohol, such as ethanol.
  • phosphotransacetylase or "PTA” is intended to include the enzyme capable of converting Acetyl CoA into acetate.
  • acetate kinase or "ACK” is intended to include the enzyme capable of converting Acetyl CoA into acetate.
  • pyruvate formate lyase or "PFL” is intended to include the enzyme capable of converting pyruvate into Acetyl CoA.
  • pyruvate decarboxylase activity is intended to include the ability of a polypeptide to enzymatically convert pyruvate into acetaldehyde (e.g., "pyruvate decarboxylase” or "PDC”).
  • the activity of a selected polypeptide encompasses the total enzymatic activity associated with the produced polypeptide, comprising, e.g., the superior substrate affinity of the enzyme, thermostability, stability at different pHs, or a combination of these attributes.
  • ethanologenic is intended to include the ability of a microorganism to produce ethanol from a carbohydrate as a fermentation product.
  • the term is intended to include, but is not limited to, naturally occurring ethanologenic organisms, ethanologenic organisms with naturally occurring or induced mutations, and ethanologenic organisms which have been genetically modified.
  • the terms “fermenting” and “fermentation” are intended to include the enzymatic process (e.g., cellular or acellular, e.g., a lysate or purified polypeptide mixture) by which ethanol is produced from a carbohydrate, in particular, as a product of fermentation.
  • enzymatic process e.g., cellular or acellular, e.g., a lysate or purified polypeptide mixture
  • the term "secreted” is intended to include the movement of polypeptides to the periplasmic space or extracellular milieu.
  • the term “increased secretion” is intended to include situations in which a given polypeptide is secreted at an increased level (i.e., in excess of the naturally-occurring amount of secretion).
  • the term “increased secreted” refers to an increase in secretion of a given polypeptide that is at least about 10% or at least about 100%, 200%, 300%, 400%, 500%, 600%, 700%, 800%, 900%), 1000%), or more, as compared to the naturally-occurring level of secretion.
  • secretory polypeptide is intended to include any polypeptide(s), alone or in combination with other polypeptides, that facilitate the transport of another polypeptide from the intracellular space of a cell to the extracellular milieu.
  • the secretory polypeptide(s) encompass all the necessary secretory polypeptides sufficient to impart secretory activity to a Gram-negative or Gram-positive host cell.
  • secretory proteins are encoded in a single region or locus that may be isolated from one host cell and transferred to another host cell using genetic engineering.
  • the secretory polypeptide(s) are derived from any bacterial cell having secretory activity.
  • the secretory polypeptide(s) are derived from a host cell having Type II secretory activity.
  • the host cell is a thermophilic bacterial cell.
  • the term "derived from” is intended to include the isolation (in whole or in part) of a polynucleotide segment from an indicated source or the purification of a polypeptide from an indicated source.
  • the term is intended to include, for example, direct cloning, PCR amplification, or artificial synthesis from or based on a sequence associated with the indicated polynucleotide source.
  • thermophilic an organism that thrives at a temperature of about
  • mammalsophilic is meant an organism that thrives at a temperature of about 20-
  • organic acid is art-recognized.
  • Organic acid also includes certain organic solvents such as ethanol.
  • lactic acid refers to the organic acid 2-hydroxypropionic acid in either the free acid or salt form.
  • the salt form of lactic acid is referred to as "lactate” regardless of the neutralizing agent, i.e., calcium carbonate or ammonium hydroxide.
  • acetic acid refers to the organic acid methanecarboxylic acid, also known as ethanoic acid, in either free acid or salt form.
  • the salt form of acetic acid is referred to as "acetate.”
  • Certain embodiments of the present invention provide for the "insertion," ⁇ e.g., the addition, integration, incorporation, or introduction) of certain genes or particular polynucleotide sequences within thermophilic or mesophilic microorganisms, which insertion of genes or particular polynucleotide sequences may be understood to encompass "genetic modification(s)” or “transformation(s)” such that the resulting strains of said thermophilic or mesophilic microorganisms may be understood to be “genetically modified” or “transformed.”
  • strains may be of bacterial, fungal, or yeast origin.
  • thermophilic or mesophilic microorganisms which "inactivation” or “deletion” of genes or particular polynucleotide sequences may be understood to encompass “genetic modification(s)” or “transformation(s)” such that the resulting strains of said thermophilic or mesophilic microorganisms may be understood to be “genetically modified” or “transformed.”
  • strains may be of bacterial, fungal, or yeast origin.
  • CBP organism is intended to include microorganisms of the invention, e.g., microorganisms that have properties suitable for CBP.
  • the genes or particular polynucleotide sequences are inserted to activate the activity for which they encode, such as the expression of an enzyme.
  • genes encoding enzymes in the metabolic production of ethanol e.g., enzymes that metabolize pentose and/or hexose sugars, may be added to a mesophilic or thermophilic organism.
  • the enzyme may confer the ability to metabolize a pentose sugar and be involved, for example, in the D-xylose pathway and/or L-arabinose pathway.
  • the genes or particular polynucleotide sequences are partially, substantially, or completely deleted, silenced, inactivated, or down-regulated in order to inactivate the activity for which they encode, such as the expression of an enzyme.
  • Deletions provide maximum stability because there is no opportunity for a reverse mutation to restore function.
  • genes can be partially, substantially, or completely deleted, silenced, inactivated, or down-regulated by insertion of nucleic acid sequences that disrupt the function and/or expression of the gene (e.g., PI transduction or other methods known in the art).
  • strains of thermophilic or mesophilic microorganisms of interest may be engineered by site directed homologous recombination to knockout the production of organic acids.
  • RNAi or antisense DNA may be used to partially, substantially, or completely silence, inactivate, or down-regulate a particular gene of interest.
  • the genes targeted for deletion or inactivation as described herein may be endogenous to the native strain of the microorganism, and may thus be understood to be referred to as "native gene(s)" or “endogenous gene(s).”
  • An organism is in "a native state” if it has not been genetically engineered or otherwise manipulated by the hand of man in a manner that intentionally alters the genetic and/or phenotypic constitution of the organism.
  • wild-type organisms may be considered to be in a native state.
  • the gene(s) targeted for deletion or inactivation may be non-native to the organism.
  • Biomass can include any type of biomass known in the art or described herein.
  • lignocellulosic material means any type of biomass comprising cellulose, hemicellulose, lignin, or combinations thereof, such as but not limited to woody biomass, forage grasses, herbaceous energy crops, non-woody-plant biomass, agricultural wastes and/or agricultural residues, forestry residues and/or forestry wastes, paper-production sludge and/or waste paper sludge, waste-water-treatment sludge, municipal solid waste, corn fiber from wet and dry mill corn ethanol plants, and sugar-processing residues.
  • hemicellulosics mean the non-lignin, non- cellulose elements of lignocellulosic material, such as but not limited to hemicellulose (i.e., comprising xyloglucan, xylan, glucuronoxylan, arabinoxylan, mannan, glucomannan, and galactoglucomannan, inter alia), pectins (e.g., homogalacturonans, rhamnogalacturonan I and II, and xylogalacturonan), and proteoglycans (e.g., arabinogalactan-protein, extensin, and proline-rich proteins).
  • hemicellulose i.e., comprising xyloglucan, xylan, glucuronoxylan, arabinoxylan, mannan, glucomannan, and galactoglucomannan, inter alia
  • pectins e.g., homogalacturonans, r
  • the lignocellulosic material can include, but is not limited to, woody biomass, such as recycled wood pulp fiber, sawdust, hardwood, softwood, and combinations thereof; grasses, such as switch grass, cord grass, rye grass, reed canary grass, miscanthus, or a combination thereof; sugar-processing residues, such as but not limited to sugar cane bagasse; agricultural wastes, such as but not limited to rice straw, rice hulls, barley straw, corn cobs, cereal straw, wheat straw, canola straw, oat straw, oat hulls, and corn fiber; stover, such as but not limited to soybean stover, com stover; and forestry wastes, such as but not limited to recycled wood pulp fiber, sawdust, hardwood (e.g., poplar, oak, maple, birch, willow), softwood, or any combination thereof.
  • woody biomass such as recycled wood pulp fiber, sawdust, hardwood, softwood, and combinations thereof
  • grasses such as switch grass
  • Lignocellulosic material may comprise one species of fiber; alternatively, lignocellulosic material may comprise a mixture of fibers that originate from different lignocellulosic materials.
  • Other lignocellulosic materials include agricultural wastes, such as cereal straws, including wheat straw, barley straw, canola straw and oat straw; corn fiber; stovers, such as corn stover and soybean stover; grasses, such as switch grass, reed canary grass, cord grass, and miscanthus; or combinations thereof.
  • Paper sludge is also a viable feedstock for lactate or acetate production.
  • Paper sludge is solid residue arising from pulping and paper-making, and is typically removed from process wastewater in a primary clarifier.
  • the cost of sludge disposal equates to $5/ton of paper that is produced for sale.
  • the cost of disposing of wet sludge is a significant incentive to convert the material for other uses, such as conversion to ethanol.
  • Processes provided by the present invention are widely applicable.
  • the saccharification and/or fermentation products may be used to produce ethanol or higher value added chemicals, such as organic acids, aromatics, esters, acetone and polymer intermediates.
  • Lignocellulosic materials generally require some method of pretreatment to increase the accessibility of lignocellulosics and other components to enzymes.
  • Pretreatment can include any method or type of pretreatment known in the art.
  • steam-explosion has been identified as a low cost and high yield technology, along with low-pressure steam autohydro lysis.
  • steam explosion heats wetted lignocellulose to high temperatures (e.g., about 160°C to about 230°C) and releases the pressure immediately. Due to rapid decompression, which flashes the water trapped in fibers, physical size reduction occurs.
  • the high temperatures remove acetic acid from hemicellulose, so this process results in some autohydro lysis of the biomass.
  • Additional chemical agents such as sulfuric acid or ammonia (e.g., gaseous, anhydrous liquid, or ammonium hydroxide), may be added to aid in the hydrolysis.
  • the pretreated cellulose can then be sterilized, if desired, to prevent growth of other microorganisms during the fermentation reaction.
  • the optimum reaction conditions vary depending on the starting material.
  • the lignocellulosic materials may be soaked in water or other suitable liquid(s) prior to the addition of steam or ammonia or both.
  • the excess water may be drained off the lignocellulosic materials.
  • the soaking may be done prior to conveying into a reactor, or subsequent to entry (i.e., inside a pretreatment reactor).
  • the terms "reactor” and "pretreatment reactor” used herein mean any vessel suitable for practicing a method of the present invention.
  • the dimensions of the pretreatment reactor should be sufficient to accommodate the lignocellulose material conveyed into and out of the reactor, as well as additional headspace around the material. In a non-limiting example, the headspace extends about one foot around the space occupied by the materials.
  • the pretreatment reactor should be constructed of a material capable of withstanding the pretreatment conditions. Specifically, the construction of the reactor should be such that the pH, temperature and pressure do not affect the integrity of the vessel.
  • the size range of the substrate material varies widely and depends upon the type of substrate material used as well as the requirements and needs of a given process.
  • the lignocellulosic raw material may be prepared in such a way as to permit ease of handling in conveyors, hoppers and the like.
  • the chips obtained from commercial chippers are suitable; in the case of straw it is sometimes desirable to chop the stalks into uniform pieces about 1 to about 3 inches in length.
  • the size of the substrate particles prior to pretreatment may range from less than a millimeter to inches in length. The particles need only be of a size that is reactive.
  • Ultrasound treatments may also be applied to processes of the present invention.
  • CBP Consolidated bioprocessing
  • Xylose is a five-carbon monosaccharide that can be metabolized into useful products by a variety of organisms. There are two main pathways of xylose metabolism, each unique in the characteristic enzymes they utilize. One pathway is called the "Xylose Reductase-Xylitol Dehydrogenase" or XR-XDH pathway. Xylose reductase (XR) and xylitol dehydrogenase (XDH) are the two main enzymes used in this method of xylose degradation. XR, encoded by the XYL1 gene, is responsible for the reduction of xylose to xylitol and is aided by cofactors NADH or NADPH.
  • Xylitol is then oxidized to xylulose by XDH, which is expressed through the XYL2 gene, and accomplished exclusively with the cofactor NAD+. Because of the varying cofactors needed in this pathway and the degree to which they are available for usage, an imbalance can result in an overproduction of xylitol byproduct and an inefficient production of desirable ethanol. Varying expression of the XR and XDH enzyme levels have been tested in the laboratory in the attempt to optimize the efficiency of the xylose metabolism pathway.
  • Xylose Isomerase The other pathway for xylose metabolism is called the "Xylose Isomerase" (XI) pathway.
  • Enzyme XI is responsible for direct conversion of xylose into xylulose, and does not proceed via a xylitol intermediate. Both pathways create xylulose, although the enzymes utilized are different.
  • XK xylulokinase
  • XKSl enzyme xylulokinase
  • Microorganisms are particularly diverse in the fermentation products that are produced by different genera. These products include organic acids, such as lactic, acetic, succinic, and butyric, as well as neutral products, such as ethanol, butanol, acetone, and butanediol. Aspects of the present invention relate to microorganisms with the ability to produce enzymes, which are used to depolymerize the hemicellulosic portions of lignocellulosic biomass materials ⁇ e.g., hemicellulose, pectins, proteoglycans).
  • aspects of the present invention provide for a novel approach wherein microorganisms that produce such enzymes are implemented in the consolidated bioprocessing of lignocellulosic materials, more particularly in combination with a sugar stream such as, but not limited to molasses, cane juice, or starch ⁇ e.g., corn, wheat, potato).
  • a sugar stream such as, but not limited to molasses, cane juice, or starch ⁇ e.g., corn, wheat, potato.
  • methods of the present invention provide for an approach wherein the enzyme specifically targets the hemicellulosic fractions of the biomass (i.e., non-lignin, non-cellulose elements such as but not limited to hemicellulose, pectins, and proteoglycans).
  • the enzyme specifically targets the hemicellulosic fractions of the biomass (i.e., non-lignin, non-cellulose elements such as but not limited to hemicellulose, pectins, and proteoglycans).
  • the organisms will be thermophilic (i.e., thrives at a temperature of about 45°C or higher), thus able to thrive at the temperature of optimal enzymatic activity.
  • all microorganisms implemented in alternate processes were not able to thrive at optimal temperatures for enzymatic hydrolysis.
  • metabolic engineering With the introduction of recombinant DNA technology it has become possible to clone genes from one organism and transfer them to another organism, delete genes in the genome and also vary the expression levels of genes. It is thus possible to perform directed modifications of metabolic pathways.
  • This new discipline is called metabolic engineering and has been defined as "Improvement of cellular activities by manipulation of enzymatic, transport, and regulatory functions of the cell with the use of recombinant DNA technology” and “Purposeful modification of intermediary metabolism using recombinant DNA techniques.”
  • metabolic engineering is characterized by an analysis step and a synthesis step.
  • the microorganism is physiologically characterized and evaluated using, for instance, MFA (metabolic flux analysis), enzymatic activity measurements or expression analysis.
  • MFA metabolic flux analysis
  • the analysis provides information on where genetic modifications may improve the performance of the microorganism.
  • the synthesis step involves the construction of a strain, with genetic modifications based on the analysis, using recombinant DNA technology. The new recombinant strain is then analyzed using the same methodology as for its parental strain. If the analysis reveals that further improvement is required, new targets for genetic manipulation are identified followed by a new round of synthesis and analysis.
  • aspects of the present invention are related to microorganisms with the ability to produce enzymes, which are used to depolymerize the hemicellulosic portions of lignocellulosic biomass materials (i.e., the non-lignin, non-cellulose elements such as but not limited to hemicellulose, pectins, and proteoglycans).
  • lignocellulosic biomass materials i.e., the non-lignin, non-cellulose elements such as but not limited to hemicellulose, pectins, and proteoglycans.
  • Pectin is a heterosaccharide derived from the cell wall of plants. Pectins vary in their chain lengths, complexity and the order of each of the monosaccharide units. Pectin is composed of four main polysaccharide types: homogalacturonan, which is composed of repeated D-galacturonic acid monosaccharide subunits, that are methyl-esterified to a varying degree; rhamnogalacturonan I, which is composed of alternating L-rhamnose and D-galacturonic acid subunits that contain a-l,5-L-arabinan and P-l,4-D-galactan side chains; rhamnogalacturonan II, which is a complex, highly branched polysaccharide; and xylogalacturonans.
  • the gelling characteristics of different pectins are influenced greatly by the degree of esterification of the molecule. Pectin releases small amounts of methane in a non-en
  • Proteoglycans represent a special class of glycoproteins that are heavily glycosylated. They consist of a core protein with one or more covalently attached glycosaminoglycan chain(s). These glycosaminoglycan (GAG) chains are long, linear carbohydrate polymers. In certain embodiments, the present invention relates to the proteoglycans arabinogalactan-protein, extensin, and/or proline-rich proteins. [0084] Hemicelluloses are heteropolysaccharides formed from a variety of monomers.
  • Hemicellulase enzymes are broadly categorized - e.g., as a glucanase, xylanase, or mannanase - based on their ability to catalyze the hydrolysis of heteropolysaccharides composed of glucan, xylan, or mannan, respectively.
  • aspects of the present invention relate to microorganisms that produce enzymes, which act to depolymerize hemicellulosic portions of lignocellulosic biomass.
  • Such enzymes may also be active primarily on side-chains ⁇ e.g., arabinofuranosidase).
  • Such enzymes may be active for de-branching.
  • Such enzymes may be active for methylation and/or other chemical modifications of biomass polysaccharides.
  • Said microorganisms can be cultured per se or can be used as sources of genetic information with which to engineer other microorganisms to produce the enzyme.
  • enzymes useful in the present invention may have a pH profile for activity in catalyzing said degradation that ranges from about pH 4.5 to about pH 11 and may be active at a temperature of at least about 45°C to about 60°C.
  • the present invention relates to enzymes selected from the group consisting of: endoglucanase, exoglucanase, endoxylanase, exoxylanase, endogalactanase, endoarabinase, cellobiohydrolase, exo-P-l,3-glucanase, endo-P-l,4-glucanase, endo-P-D-mannanase, endo-P"l,4-mannanase, ⁇ -mannanase, ⁇ -mannosidase, endo-P-xylanase, a-galactosidase, polygalacturonase, a-glucuronidase, cellodextasaccharide,
  • some recombinant microorganisms useful in the present invention have been transformed with heterologous sequences that encode for enzymes involved in the metabolism of hemicellulose to ethanol, including, but not limited to xylose isomerase, xylose reductase, xylitol dehydrogenase, xylulokinase, transaldolase, and transketolase.
  • heterologous sequences that encode for enzymes involved in the metabolism of hemicellulose to ethanol, including, but not limited to xylose isomerase, xylose reductase, xylitol dehydrogenase, xylulokinase, transaldolase, and transketolase.
  • the nucleotide sequences of representatives of said encoding genes are publicly available without restriction.
  • mannans such as a galactan or a glucomannan
  • various microorganisms including bacteria and fungi, and that they also occur in some animals and in numerous plants.
  • microorganisms that produce such mannanases are species of Aeromonas, Aspergillus, Streptomyces, Rhodococcus, and Bacillus (e.g., B. circulans).
  • a hemicellulase capable of catalyzing the degradation of mannan-containing hemicellulose can be produced using microorganisms that synthesize the enzyme.
  • Microorganisms possessing the ability to produce a hemicellulase can be isolated by conventional methods from soil, where they comprise a reproducible, finite subsection of indigenous microflora, and they can also be produced by transforming another microorganism of choice, such as B. subtilis or B. brevis. Transformation via standard recombinant DNA techniques may proceed with hemicellulase-encoding DNA obtained from e.g. , soil microflora.
  • Mannanase can be produced by fungi or bacteria, for example, by microorganisms belonging to the following genera: Trichoderma (e.g., T. reesei), Aspergillus (e.g., A. niger, A. aculeatus), Phanerochaete (e.g., P. chrysosporium), Penicillium (e.g., P. janthinelium, P. digitatum), and Bacillus.
  • Trichoderma e.g., T. reesei
  • Aspergillus e.g., A. niger, A. aculeatus
  • Phanerochaete e.g., P. chrysosporium
  • Penicillium e.g., P. janthinelium, P. digitatum
  • Bacillus e.g., Bacillus.
  • Xylanase can be obtained or derived from fungal and bacterial organisms, for example, Aspergillus, Disporotrichum, Penicillium, Neurospora, Fusarium, and Trichoderma.
  • a Bacillus xylanase can be obtained from, for example, B. halodurans, B. pumilus, B. agaradhaerens, B. circulans, B. polymyxa, B. stearothermophilus, and B. subtilis.
  • Fungal xylanase can be obtained from yeast or filamentous fungal polypeptides, and for example, derived from the following fungal genera: Aspergillus, Aureobasidium, Emericella, Fusarium, Gaeumannomyces, Humicola, Lentinula, Magnaporthe, Neocallimastix, Norcardiopsis, Orpinomyces, Paecilomyces, Penicillium, Pichia, Schizophyllum, Talaromyces, Thermomyces, and Trichoderma.
  • xylose fermentation include the conversion of xylose to xylulose using xylose isomerase prior to fermentation by Saccharomyces cerevisiae and the development of genetically engineered strains of S. cerevisiae, which express xylose isomerase ⁇ supra).
  • Erwinia chrysanthemi is also known to produce at least two different endoglucanase activities, EGY and EGZ.
  • Host cells useful in the present invention include any prokaryotic or eukaryotic cells; for example, microorganisms selected from bacterial, algal, and yeast cells.
  • host cells thus suitable for the present invention are microorganisms, for example, of the genera Aeromonas, Aspergillus, Bacillus, Escherichia, Kluyveromyces, Pichia, Rhodococcus, Saccharomyces and Streptomyces.
  • the host cells are microorganisms.
  • the microorganism is a yeast.
  • the yeast host cell can be, for example, from the genera Saccharomyces, Kluyveromyces, Candida, Pichia, Schizosaccharomyces, Hansenula, Kloeckera, Schwanniomyces, and Yarrowia.
  • Yeast species as host cells may include, for example, S. cerevisiae, S. bulderi, S. barnetti, S. exiguus, S. uvarum, S. diastaticus, K. lactis, K. marxianus, or K. fragilis.
  • the yeast is selected from the group consisting of Saccharomyces cerevisiae, Schizzosaccharomyces pombe, Candida albicans, Pichia pastoris, Pichia stipitis, Yarrowia lipolytica, Hansenula polymorpha, Phaffia rhodozyma, Candida utilis, Arxula adeninivorans, Debaryomyces hansenii, Debaryomyces polymorphus, Schizosaccharomyces pombe and Schwanniomyces occidentalis .
  • the yeast is Saccharomyces cerevisiae.
  • the yeast is a thermotolerant Saccharomyces cerevisiae. The selection of an appropriate host is deemed to be within the scope of those skilled in the art from the teachings herein.
  • the host cell is an oleaginous cell.
  • the oleaginous host cell can be an oleaginous yeast cell.
  • the oleaginous yeast host cell can be from the genera Blakeslea, Candida, Cryptococcus, Cunninghamella, Lipomyces, Mortierella, Mucor, Phycomyces, Pythium, Rhodosporidum, Rhodotorula, Trichosporon or Yarrowia.
  • the oleaginous host cell can be an oleaginous microalgae host cell.
  • the oleaginous microalgae host cell can be from the genera Thraustochytrium or Schizochytrium.
  • Biodiesel could then be produced from the triglyceride produced by the oleaginous organisms using conventional lipid transesterification processes.
  • the oleaginous host cells can be induced to secrete synthesized lipids.
  • Embodiments using oleaginous host cells are advantageous because they can produce biodiesel from lignocellulosic feedstocks which, relative to oilseed substrates, are cheaper, can be grown more densely, show lower life cycle carbon dioxide emissions, and can be cultivated on marginal lands.
  • the host cell is a thermotolerant host cell.
  • Thermotolerant host cells can be particularly useful in simultaneous saccharification and fermentation processes by allowing externally produced cellulases and ethanol-producing host cells to perform optimally in similar temperature ranges.
  • Thermotolerant host cells can include, for example, Issatchenkia orientalis, Pichia mississippiensis, Pichia mexicana, Pichia farinosa, Clavispora opuntiae, Clavispora lusitaniae, Candida mexicana, Hansenula polymorpha and Kluyveromyces host cells.
  • the thermotolerant cell is an S. cerevisiae strain, or other yeast strain, that has been adapted to grow in high temperatures, for example, by selection for growth at high temperatures in a cytostat.
  • the host cell is a Kluyveromyces host cell.
  • the Kluyveromyces host cell can be a K lactis, K marxianus, K. blattae, K phqffii, K. yarrowii, K. aestuarii, K. dobzhanskii, K. wickerhamii K. thermotolerans, or K waltii host cell.
  • the host cell is a K. lactis, or K marxianus host cell.
  • the host cell is a K marxianus host cell.
  • the thermotolerant host cell can grow at temperatures above about 30° C, about 31° C, about 32° C, about 33° C, about 34° C, about 35° C, about 36° C, about 37° C, about 38° C, about 39° C, about 40° C, about 41° C or about 42° C.
  • thermotolerant host cell can produce ethanol from cellulose at temperatures above about 30° C, about 31° C, about 32° C, about 33° C, about 34° C, about 35° C, about 36° C, about 37° C, about 38° C, about 39° C, about 40° C, about 41° C, about 42° C, or about 43 °C, or about 44 °C, or about 45 °C, or about 50° C.
  • the thermotolerant host cell can grow at temperatures from about 30° C to 60° C, about 30° C to 55° C, about 30° C to 50° C, about 40° C to 60° C, about 40° C to 55° C or about 40° C to 50° C.
  • the thermotolerant host cell can produce ethanol from cellulose at temperatures from about 30° C to 60° C, about 30° C to 55° C, about 30° C to 50° C, about 40° C to 60° C, about 40° C to 55° C or about 40° C to 50° C.
  • the host cell has the ability to metabolize xylose.
  • xylose-utilizing technology can be found in the following publications: Kuyper, M. et al., FEMS Yeast Res. 4: 655-64 (2004), Kuyper, M. et al, FEMS Yeast Res. 5:399-409 (2005), and Kuyper, M. et al, FEMS Yeast Res. 5:925-34 (2005), which are herein incorporated by reference in their entirety.
  • xylose-utilization can be accomplished in S.
  • xylose isomerase gene e.g., from the anaerobic fungus Piromyces sp. E2
  • XylA xylose isomerase gene
  • E2 overexpressing five S. cerevisiae enzymes involved in the conversion of xylulose to glycolytic intermediates (xylulokinase, ribulose 5-phosphate isomerase, ribulose 5- phosphate epimerase, transketolase and transaldolase) and deleting the GRE3 gene encoding aldose reductase to minimize xylitol production.
  • the host cells can contain antibiotic markers or can contain no antibiotic markers.
  • the host cell is microorganism that is a species of the genera Thermoanaerobacterium, Thermoanaerobacter, Clostridium, Geobacillus, Saccharococcus, Paenibacillus, Bacillus, Caldicellulosiruptor, Anaerocellum, or Anoxybacillus.
  • the host cell is a bacterium selected from the group consisting of: Thermoanaerobacterium thermo sulfur igenes, Thermoanaerobacterium aotearoense, Thermoanaerobacterium polys accharolyticum, Thermoanaerobacterium zeae, Thermoanaerobacterium xylanolyticum,
  • host cells are genetically engineered (transduced or transformed or transfected) with the polynucleotides encoding cellulases which are described in more detail herein.
  • the polynucleotides encoding cellulases can be introduced to the host cell on a vector, which may be, for example, a cloning vector or an expression vector comprising a sequence encoding a heterologous cellulase.
  • the host cells can comprise polynucleotides as integrated copies or plasmid copies.
  • the host cells useful in the methods of the invention can express one or more heterologous cellulase polypeptides.
  • the host cell comprises a combination of polynucleotides that encode heterologous cellulases or fragments, variants or derivatives thereof.
  • the host cell can, for example, comprise multiple copies of the same nucleic acid sequence, for example, to increase expression levels, or the host cell can comprise a combination of unique polynucleotides.
  • the host cell comprises a single polynucleotide that encodes a heterologous cellulase or a fragment, variant or derivative thereof.
  • host cells expressing a single heterologous cellulase can be used in co-culture with other host cells of the invention comprising a polynucleotide that encodes at least one other heterologous cellulase or fragment, variant or derivative thereof.
  • Introduction of a polynucleotide encoding a heterologous cellulase into a host cell can be done by methods known in the art.
  • Introduction of polynucleotides encoding heterologous cellulases into, for example yeast host cells can be effected by lithium acetate transformation, spheroplast transformation, or transformation by electroporation, as described in Current Protocols in Molecular Biology, 13.7.1-13.7.10.
  • Introduction of the construct in other host cells can be effected by calcium phosphate transfection, DEAE-Dextran mediated transfection, or electroporation. (Davis, L. et al., Basic Methods in Molecular Biology, (1986)).
  • the transformed host cells or cell cultures, as described above, can be further analyzed for hydrolysis of cellulose (e.g., by a sugar detection assay), for a particular type of cellulase activity (e.g., by measuring the individual endoglucanase, cellobiohydrolase or ⁇ glucosidase activity) or for total cellulase activity.
  • Endoglucanase activity can be determined, for example, by measuring an increase of reducing ends in an endoglucanase specific CMC substrate.
  • Cellobiohydrolase activity can be measured, for example, by using insoluble cellulosic substrates such as the amorphous substrate phosphoric acid swollen cellulose (PASC) or microcrystalline cellulose (Avicel) and determining the extent of the substrate's hydrolysis.
  • PASC amorphous substrate phosphoric acid swollen cellulose
  • Avicel microcrystalline cellulose
  • B-glucosidase activity can be measured by a variety of assays, e.g., using cellobiose.
  • a total cellulase activity which includes the activity of endoglucanase, cellobiohydrolase and B-glucosidase, can hydrolyze crystalline cellulose synergistically.
  • Total cellulase activity can thus be measured using insoluble substrates including pure cellulosic substrates such as Whatman No. 1 filter paper, cotton linter, microcrystalline cellulose, bacterial cellulose, algal cellulose, and cellulose-containing substrates such as dyed cellulose, alpha-cellulose or pretreated lignocellulose.
  • Specific activity of cellulases can also be detected by methods known to one of ordinary skill in the art, such as by the Avicel assay (described supra) that would be normalized by protein (cellulase) concentration measured for the sample.
  • a cellulase can be any enzyme involved in cellulase digestion, metabolism and/or hydrolysis, including an endoglucanase, exogluconase, or ⁇ -glucosidase.
  • the transformed host cells or cell cultures are assayed for ethanol production.
  • Ethanol production can be measured by techniques known to one or ordinary skill in the art, e.g., by a standard HPLC refractive index method.
  • Recombinant host cells useful in the invention may be engineered for optimal expression and secretion of hemicellulosic depolymerization activities.
  • recombinant enteric bacteria such as Escherichia and Klebsiella
  • a recombinant enteric bacterium can be produced that expresses two different endoglucanases celY and celZ, where each is under the transcriptional control of a surrogate promoter for optimal expression in a particular ratio. See U.S. Patent No. 7,026,152, which is hereby incorporated by reference.
  • the hosts are further modified to include secretory protein or proteins that allow for the increased production and/or secretion of enzymes from the cell.
  • the hosts may be further modified to include exogenous ethanologenic genes derived from an efficient ethanol producer (e.g., Zymomonas mobilis). Accordingly, these hosts are capable of expressing high levels of proteins that may be used alone or in combination with other enzymes or recombinant hosts for the efficient degradation of lignocellulosic biomass and the subsequent production of alcohol.
  • such additional enzyme is a secretory enzyme.
  • the host cell may be ethanologenic, e.g., E. coli K04 (ATCC 55123), E. coli KOl l (ATCC 55124), E. coli K012 (ATCC 55125) and E. coli LY01 (ATCC 11303) K. oxytoca M5A1, and K. oxytoca P2 (ATCC 55307), K. oxytoca strain P2 (pCPP2006), K. oxytoca strain SZ6 (pCPP2006), K. oxytoca strain SZ21 (pCPP2006), ox K. oxytoca strain SZ22 (pCPP2006).
  • E. coli K04 ATCC 55123
  • E. coli KOl l ATCC 55124
  • E. coli K012 ATCC 55125
  • E. coli LY01 ATCC 11303
  • K. oxytoca M5A1 K. oxytoca P2
  • K. oxytoca strain P2 pCPP2006
  • a recombinant ethanologenic bacterium contains at least one heterologous polynucleotide segment encoding at least one enzyme with hemicellulosic depolymerization activities.
  • the recombinant ethanologenic bacteria contains more than one heterologous polynucleotide segment, which segments encode enzymes of the present invention.
  • the recombinant host is a Gram-negative bacterium. In yet other embodiments, the recombinant host is from the family Enterobacteriaceae.
  • the ethanologenic hosts of U.S. Pat. No. 5,821,093, which is hereby incorporated by reference, for example, are suitable hosts and include, in particular, E. coli strains K04 (ATCC 55123), KOl l (ATCC 55124), and K012 (ATCC 55125), and Klebsiella oxytoca strain P2 (ATCC 55307).
  • a non-ethanologenic host of the present invention may be converted into an ethanologenic host (such as the above-mentioned strains) by introducing, for example, ethanologenic genes from an efficient ethanol producer, such as Zymomonas mobilis.
  • an efficient ethanol producer such as Zymomonas mobilis.
  • This type of genetic engineering using standard techniques, results in a recombinant host capable of efficiently fermenting sugar into ethanol.
  • the LY01 ethanol tolerant strain (ATCC 11303) may be employed as described in published PCT international application WO 98/45425, and this published application is hereby incorporated by reference (see also, e.g., Yomano et al. (1998) J. Ind. Micro. & Bio. 20: 132-138).
  • Certain embodiments relate to use of a non-ethanologenic recombinant host, e.g.,
  • E. coli strain B E. coli strain DH5a, or Klebsiella oxytoca strain M5A1.
  • These strains may be used to express at least one desired polypeptide, e.g., a hemicellulase, using techniques described herein.
  • these recombinant hosts may be used in conjunction with another recombinant host that expresses yet another desirable polypeptide, e.g., a different enzyme.
  • the non-ethanologenic host cell(s) may be used in conjunction with an ethanologenic host cell.
  • non- ethanologenic host(s) for carrying out the synergistic depolymerization of a complex hemicellulose material may be followed by the use of an ethanologenic host for fermenting the depolymerized sugar. Accordingly, it will be appreciated that these reactions may be carried out serially or contemporaneously using homogeneous or mixed cultures of non-ethanologenic and ethanologenic recombinant hosts.
  • one or more genes for fermenting a hemicellulosic substrate into ethanol are provided on a plasmid or integrated into the host chromosome.
  • genes for fermenting a sugar substrate into ethanol e.g., pyruvate decarboxylase and/or alcohol dehydrogenase
  • an artificial operon such as the PET operon as described in U.S. Pat. No. 5,821,093, which is hereby incorporated by reference.
  • aspects of the present invention relate to techniques and vectors for introducing multiple genes into a suitable host (see, e.g., Current Protocols in Molecular Biology, eds.
  • a single genetic construct can encode all of the necessary gene products (e.g., a glucanase, an endoglucanase, an exoglucanase, a secretory protein(s), pyruvate decarboxylase, alcohol dehydrogenase) for performing simultaneous saccharification and fermentation (SSF) or consolidated bioprocessing (CBP).
  • SSF simultaneous saccharification and fermentation
  • CBP consolidated bioprocessing
  • Multiple strategies are encompassed for the development of microorganisms with the combination of substrate -utilization and product-formation properties required for CBP.
  • the “native cellulo lytic strategy” involves engineering naturally occurring cellulolytic microorganisms to improve product-related properties, such as yield and titer.
  • the “recombinant cellulolytic strategy” involves engineering natively non-cellulolytic organisms that exhibit high product yields and titers to express a heterologous cellulase system that enables cellulose utilization or hemicellulose
  • Clostridium thermocellum is a thermophilic bacterium that has among the highest rates of cellulose utilization reported.
  • Other organisms of interest are xylose-utilizing thermophiles such as Thermoanaerobacterium saccharolyticum and Thermoanaerobacterium thermosaccharolyticum.
  • Organic acid production may be responsible for the low concentrations of produced ethanol generally associated with these organisms.
  • one objective is to eliminate production of acetic and lactic acid in these organisms via metabolic engineering.
  • thermocellum isolates from nature have been characterized. See McLaughlin et al. (2002) Environ. Sci. Technol. 36:2122. Metabolic engineering of thermophilic, saccharolytic bacteria is an active area of interest, and knockout of lactate dehydrogenase in T. saccharolyticum has recently been reported. See Desai et al. (2004) Appl. Microbiol. Biotechnol. 65:600. Knockout of acetate kinase and phosphotransacetylase in this organism is also possible.
  • CBP processing strategy requires that cellulosic hydrolysis be viewed in terms of a microbial paradigm.
  • This microbial paradigm naturally leads to an emphasis on different fundamental issues, organisms, cellulasic systems, and applied milestones compared to those of the enzymatic paradigm.
  • C. thermocellum has been a model organism because of its high growth rate on cellulose together with its potential utility for CBP.
  • organisms useful in the present invention may be applicable to the process known as simultaneous saccharification and fermentation (SSF), which is intended to include the use of said microorganisms and/or one or more recombinant hosts (or extracts thereof, including purified or unpurified extracts) for the contemporaneous degradation or depolymerization of a complex sugar ⁇ i.e., cellulosic biomass) and bioconversion of that sugar residue into ethanol by fermentation.
  • SSF simultaneous saccharification and fermentation
  • DNA encoding an enzyme that acts to depolymerize hemicellulosic fractions can be isolated and used, via known procedures, to transform a suitable host organism such that the enzyme is produced by the recombinant host in commercially useful amounts.
  • Said enzyme-encoding DNA can be isolated by screening nucleic acid libraries generated from microorganisms expressing a hemicellulase according to the present invention. Such libraries would be screened by means of oligonucleotide probes that are complementary to a polynucleotide encoding; for example, a portion of the N-terminus of an enzyme within the present invention.
  • nucleotide sequences of the genes encoding heterologous enzymes involved in production of ethanol from pentoses ⁇ e.g., xylose are known and publicly available.
  • molecular biology techniques e.g., restriction endonuclease cleavage/re-ligation, PCR, etc.
  • Such sequences, or portions of these sequences can be manipulated to provide microorganisms according to the present invention.
  • Such genetic engineering techniques are well within the ordinarily skilled artisan's knowledge and abilities, and can be performed without undue or excessive experimentation.
  • a probe as a template for generating other probes useful for isolating an enzyme- encoding polynucleotide according to the present invention, e.g. , based on the N-terminal sequence described above.
  • a probe could be used in a known manner to screen a genomic or cDNA library as described above, or to synthesize polymerase chain reaction (PCR) probes for use in amplifying a cDNA generated from an isolated R A, which codes for an enzyme of the present invention.
  • PCR polymerase chain reaction
  • Such a cDNA could then be cloned into a suitable expression vector and employed to transform a host organism.
  • a suitable polynucleotide in this regard would preferably comprise a nucleotide sequence, corresponding to the desired amino-acid sequence, that is optimized for the host of choice with regard to codon usage, the initiation of translation, and the expression of sufficient amounts of enzyme that acts to depolymerize hemicellulosics.
  • a vector selected for transforming the chosen host organism with such a polynucleotide molecule should also allow for efficient maintenance and transcription of the sequence encoding the polypeptide. Such a vector is readily available or derivable from commercial sources, and is suited to a particular host cell employed for expressing a hemicellulase.
  • heterologous cellulases in a host cell can be used advantageously to produce ethanol from cellulosic sources.
  • Cellulases from a variety of sources can be heterologously expressed to successfully increase efficiency of ethanol production.
  • the cellulases can be from fungi, bacteria, plant, protozoan or termite sources.
  • the cellulase is a H. grisea, T. aurantiacus, T. emersonii, T. reesei, C. lacteus, C. formosanus, N. takasagoensis, C. acinaciformis, M. darwinensis, N. walkeri, S.
  • multiple cellulases from a single organism are co- expressed in the same host cell.
  • multiple cellulases from different organisms are co-expressed in the same host cell.
  • cellulases from two, three, four, five, six, seven, eight, nine or more organisms can be co-expressed in the same host cell.
  • the invention can encompass co-cultures of microorganisms, such as yeast strains, wherein the microorganisms express different cellulases.
  • Co- cultures can include microorganisms, such as yeast strains, expressing heterologous cellulases from the same organisms or from different organisms.
  • Co-cultures can include microorganisms, such as yeast strains, expressing cellulases from two, three, four, five, six, seven, eight, nine or more organisms.
  • Cellulases of useful in the methods of the invention include both endoglucanases or exoglucanases.
  • the cellulases can be, for example, endoglucanases, ⁇ -glucosidases or cellobiohydrolases.
  • the endoglucanase(s) can be an endoglucanase I or an endoglucanase II isoform, paralogue or orthologue.
  • the endoglucanase expressed by the host cells of the present invention can be recombinant endo-l,4-P-glucanase.
  • the endoglucanase is a T. reesei, C.
  • lacteus C. formosanus, N. takasagoensis, C. acinaciformis, M. darwinensis, N. walkeri, R. speratus Aspergillus kawachii, Heterodera schachtii, H. jecorina, Orpinomycess, Irpex lacteus, C. lucknowense, C. globosum, Aspergillus terreus, Aspergillus fumigatus, Neurospora crassa or Acremonium thermophilum endoglucanase.
  • Fragments of cellobiohydrolase, endoglucanase or beta-glucosidase polypeptides encompass domains, proteolytic fragments, deletion fragments and in particular, fragments of H. grisea, T. aurantiacus, T. emersonii, T. reesei, C. lacteus, C. formosanus, N. takasagoensis, C. acinaciformis, M. darwinensis, N. walkeri, S. fibuligera, C. lucknowense, R.
  • Clostridum thermocellum Clostridium cellulolyticum
  • Clostridum josui Bacillus pumilis, Cellulomonas fimi, Saccharophagus degradans, Piromyces equii, Neocallimastix patricarum, Aspergillus kawachii, Heterodera schachtii, H.
  • Polypeptide fragments further include any portion of the polypeptide which retains a catalytic activity of cellobiohydrolase, endoglucanase or beta- glucosidase proteins.
  • the polypeptides useful in the present invention further include variants of the polypeptides.
  • a "variant" of the polypeptide can be a conservative variant, or an allelic variant.
  • a conservative variant refers to alterations in the amino acid sequence that do not adversely affect the biological functions of the protein.
  • a substitution, insertion or deletion is said to adversely affect the protein when the altered sequence prevents or disrupts a biological function associated with the protein.
  • the amino acid sequence can be altered, for example to render the peptide more hydrophobic or hydrophilic, without adversely affecting the biological activities of the protein.
  • an "allelic variant” is intended alternate forms of a gene occupying a given locus on a chromosome of an organism. Genes II, Lewin, B., ed., John Wiley & Sons, New York (1985). Non-naturally occurring variants may be produced using art-known mutagenesis techniques. Allelic variants, though possessing a slightly different amino acid sequence than those recited above, will still have the same or similar biological functions associated with the H. grisea, T. aurantiacus, T. emersonii, T. reesei, C. lacteus, C. formosanus, N. takasagoensis, C. acinaciformis, M.
  • darwinensis N. walkeri, S. fibuligera, C. lucknowense, R. speratus, Thermobifida fusca, Clostridum thermocellum, Clostridium cellulolyticum, Clostridum josui, Bacillus pumilis, Cellulomonas fimi, Saccharophagus degradans, Piromyces equii, Neocallimastix patricarum, Aspergillus kawachii, Heterodera schachtii, H.
  • variants may be generated to improve or alter the characteristics of the cellulase polypeptides. For instance, one or more amino acids can be deleted from the N-terminus or C-terminus of the secreted protein without substantial loss of biological function.
  • H. grisea T. aurantiacus, T. emersonii, T. reesei, C. lacteus,
  • the first strategy exploits the tolerance of amino acid substitutions by natural selection during the process of evolution. By comparing amino acid sequences in different species, conserved amino acids can be identified. These conserved amino acids are likely important for protein function. In contrast, the amino acid positions where substitutions have been tolerated by natural selection indicates that these positions are not critical for protein function. Thus, positions tolerating amino acid substitution could be modified while still maintaining biological activity of the protein.
  • the second strategy uses genetic engineering to introduce amino acid changes at specific positions of a cloned gene to identify regions critical for protein function. For example, site directed mutagenesis or alanine- scanning mutagenesis (introduction of single alanine mutations at every residue in the molecule) can be used. (Cunningham and Wells, Science 244: 1081-1085 (1989).) The resulting mutant molecules can then be tested for biological activity.
  • tolerated conservative amino acid substitutions involve replacement of the aliphatic or hydrophobic amino acids Ala, Val, Leu and He; replacement of the hydroxyl residues Ser and Thr; replacement of the acidic residues Asp and Glu; replacement of the amide residues Asn and Gin, replacement of the basic residues Lys, Arg, and His; replacement of the aromatic residues Phe, Tyr, and Trp, and replacement of the small-sized amino acids Ala, Ser, Thr, Met, and Gly.
  • derivatives and analogs refer to a polypeptide differing from the H. grisea, T. aurantiacus, T. emersonii, T. reesei, C. lacteus, C. formosanus, N. takasagoensis, C. acinaciformis, M. darwinensis, N. walkeri, S. fibuligera, C. lucknowense, R.
  • Clostridum thermocellum Clostridium cellulolyticum
  • Clostridum josui Bacillus pumilis, Cellulomonas fimi, Saccharophagus degradans, Piromyces equii, Neocallimastix patricarum, Aspergillus kawachii, Heterodera schachtii, H.
  • endoglucanase or beta-glucosidase polypeptides include any polypeptides which retain at least some of the activity of the corresponding native polypeptide, e.g., the exoglucanase activity, or the activity of the catalytic domain.
  • Clostridum thermocellum Clostridium cellulolyticum
  • Clostridum josui Bacillus pumilis, Cellulomonas fimi, Saccharophagus degradans, Piromyces equii, Neocallimastix patricarum, Aspergillus kawachii, Heterodera schachtii, H.
  • Derivatives can be covalently modified by substitution, chemical, enzymatic, or other appropriate means with a moiety other than a naturally occurring amino acid (for example, a detectable moiety such as an enzyme or radioisotope).
  • a detectable moiety such as an enzyme or radioisotope.
  • Examples of derivatives include fusion proteins.
  • An analog is another form of a H. grisea, T. aurantiacus, T. emersonii, T. reesei,
  • An "analog” also retains substantially the same biological function or activity as the polypeptide of interest, e.g., functions as a cellobiohydrolase.
  • An analog includes a proprotein which can be activated by cleavage of the proprotein portion to produce an active mature polypeptide.
  • the polypeptide useful in the present invention may be a recombinant polypeptide, a natural polypeptide or a synthetic polypeptide.
  • the polypeptide is a recombinant polypeptide.
  • allelic variants are also provided.
  • orthologs are also provided.
  • allelic variants and/or species homologs may be isolated and identified by making suitable probes or primers from the sequences provided herein and screening a suitable nucleic acid source for allelic variants and/or the desired homologue.
  • the host cells express a combination of heterologous cellulases.
  • the cellulases may be either tethered or secreted.
  • a protein is
  • a tethered protein may include one or more enzymatic regions that may be joined to one or more other types of regions at the nucleic acid and/or protein levels (e.g., a promoter, a terminator, an anchoring domain, a linker, a signaling region, etc.). While the one or more enzymatic regions may not be directly bound to the cell membrane or cell wall (e.g., such as when binding occurs via an anchoring domain), the protein is nonetheless considered a "tethered enzyme" according to the present specification.
  • Tethering may, for example, be accomplished by incorporation of an anchoring domain into a recombinant protein that is heterologously expressed by a cell, or by prenylation, fatty acyl linkage, glycosyl phosphatidyl inositol anchors or other suitable molecular anchors which may anchor the tethered protein to the cell membrane or cell wall of the host cell.
  • a tethered protein maybe tethered at its amino terminal end or optionally at its carboxy terminal end.
  • secreted means released into the extracellular milieu, for example into the media.
  • tethered proteins may have secretion signals as part of their immature amino acid sequence, they are maintained as attached to the cell surface, and do not fall within the scope of secreted proteins as used herein.
  • flexible linker sequence refers to an amino acid sequence which links two amino acid sequences, for example, a cell wall anchoring amino acid sequence with an amino acid sequence that contains the desired enzymatic activity.
  • the flexible linker sequence allows for necessary freedom for the amino acid sequence that contains the desired enzymatic activity to have reduced steric hindrance with respect to proximity to the cell and may also facilitate proper folding of the amino acid sequence that contains the desired enzymatic activity.
  • the tethered cellulase enzymes are tethered by a flexible linker sequence linked to an anchoring domain.
  • the anchoring domain is of CWP2 (for carboxy terminal anchoring) or FLOl (for amino terminal anchoring) from S. cerevisiae.
  • heterologous secretion signals may be added to the expression vectors of the present invention to facilitate the extra-cellular expression of cellulase proteins.
  • the heterologous secretion signal is the secretion signal from T. reesei Xyn2.
  • Fusion proteins comprising cellulases are also encompassed.
  • the fusion proteins can be a fusion of a heterologous cellulase and a second peptide.
  • the heterologous cellulase and the second peptide can be fused directly or indirectly, for example, through a linker sequence.
  • the fusion protein can comprise for example, a second peptide that is N-terminal to the heterologous cellulase and/or a second peptide that is C-terminal to the heterologous cellulase.
  • the polypeptide of the present invention comprises a first polypeptide and a second polypeptide, wherein the first polypeptide comprises a heterologous cellulase.
  • the fusion protein comprises a first and second polypeptide wherein the first polypeptide comprises a heterologous cellulase and the second polypeptide comprises a signal sequence.
  • the fusion protein comprises a first and second polypeptide, wherein the first polypeptide comprises a heterologous cellulase and the second polypeptide comprises a polypeptide used to facilitate purification or identification or a reporter peptide.
  • the polypeptide used to facilitate purification or identification or the reporter peptide can be, for example, a HIS- tag, a GST-tag, an HA-tag, a FLAG-tag, a MYC-tag, or a fluorescent protein.
  • the fusion protein comprises a first and second polypeptide, wherein the first polypeptide comprises a heterologous cellulase and the second polypeptide comprises an anchoring peptide.
  • the anchoring domain is of CWP2 (for carboxy terminal anchoring) or FLOl (for amino terminal anchoring) from S. cerevisiae.
  • the fusion protein comprises a first and second polypeptide, wherein the first polypeptide comprises a heterologous cellulase and the second polypeptide comprises a cellulose binding module (CBM).
  • CBM is from, for example, T. reesei Cbhl or Cbh2, from H. grisea Cbhl, or from C. lucknowense Cbh2b.
  • the CBM is fused to a cellobiohydrolase.
  • the fusion protein comprises a first and second polypeptide, wherein the first polypeptide comprises a heterologous cellobiohydrolase and the second polypeptide comprises a CBM.
  • the invention relates to co-cultures of host cells (e.g, microorganisms).
  • host cells e.g, microorganisms.
  • co-culture refers to growing two different strains or species of host cells together in the same vessel.
  • at least one host cell of the co-culture comprises a heterologous polynucleotide comprising a nucleic acid which encodes an endoglucanase
  • at least one host cell of the co-culture comprises a heterologous polynucleotide comprising a nucleic acid which encodes a ⁇ -glucosidase
  • at least one host cell comprises a heterologous polynucleotide comprising a nucleic acid which encodes a cellobiohydrolase.
  • the co-culture further comprises a host cell comprising a heterologous polynucleotide comprising a nucleic acid which encodes a second cellobiohydrolase.
  • the co-culture comprises two or more strains of yeast host cells, two or more strains of bacterial host cells, or a combination of one or more yeast host cells and one or more bacterial host cells.
  • the heterologous cellulases can be expressed in any combination in the two or more strains of host cells.
  • the co-cultures can include tethered cellulases, secreted cellulases or both tethered and secreted cellulases.
  • the co-culture comprises at least one yeast host cell comprising a polynucleotide encoding a secreted heterologous cellulase.
  • the co-culture comprises at least one yeast host cell comprising a polynucleotide encoding a tethered heterologous cellulase.
  • all of the heterologous cellulases in the co-culture are secreted, and in another embodiment, all of the heterologous cellulases in the co-culture are tethered.
  • other enzymes or cellulases, such as externally added cellulases may be present in the co-culture.
  • the polynucleotides encoding heterologous cellulases can be codon-optimized.
  • codon-optimized coding region means a nucleic acid coding region that has been adapted for expression in the cells of a given organism by replacing at least one, or more than one, or a significant number, of codons with one or more codons that are more frequently used in the genes of that organism.
  • CAI codon adaptation index
  • the CAI of codon optimized sequences of the present invention corresponds to between about 0.8 and 1.0, between about 0.8 and 0.9, or about 1.0.
  • a codon optimized sequence may be further modified for expression in a particular organism, depending on that organism's biological constraints. For example, large runs of "As" or "Ts" (e.g., runs greater than 4, 4, 5, 6, 7, 8, 9, or 10 consecutive bases) can be removed from the sequences if these are known to effect transcription negatively.
  • specific restriction enzyme sites may be removed for molecular cloning purposes. Examples of such restriction enzyme sites include Pad, Ascl, BamHI, Bglll, EcoRI and Xhol.
  • the DNA sequence can be checked for direct repeats, inverted repeats and mirror repeats with lengths of ten bases or longer, which can be modified manually by replacing codons with "second best" codons, i.e., codons that occur at the second highest frequency within the particular organism for which the sequence is being optimized.
  • Deviations in the nucleotide sequence that comprise the codons encoding the amino acids of any polypeptide chain allow for variations in the sequence coding for the gene. Since each codon consists of three nucleotides, and the nucleotides comprising DNA are restricted to four specific bases, there are 64 possible combinations of nucleotides, 61 of which encode amino acids (the remaining three codons encode signals ending translation).
  • the "genetic code” which shows which codons encode which amino acids is reproduced herein as Table 1. As a result, many amino acids are designated by more than one codon.
  • amino acids alanine and proline are coded for by four triplets, serine and arginine by six, whereas tryptophan and methionine are coded by just one triplet.
  • This degeneracy allows for DNA base composition to vary over a wide range without altering the amino acid sequence of the proteins encoded by the DNA.
  • Codon preference or codon bias differences in codon usage between organisms, is afforded by degeneracy of the genetic code, and is well documented among many organisms. Codon bias often correlates with the efficiency of translation of messenger RNA (mRNA), which is in turn believed to be dependent on, inter alia, the properties of the codons being translated and the availability of particular transfer RNA (tRNA) molecules.
  • mRNA messenger RNA
  • tRNA transfer RNA
  • the predominance of selected tRNAs in a cell is generally a reflection of the codons used most frequently in peptide synthesis. Accordingly, genes can be tailored for optimal gene expression in a given organism based on codon optimization.
  • Codon usage tables are readily available, for example, at http://phenotype.biosci.umbc.edu/codon/sgd/index.php (visited May 7, 2008) or at http://www.kazusa.or.jp/codon (visited March 20, 2008), and these tables can be adapted in a number of ways. See Nakamura, Y., et al. "Codon usage tabulated from the international DNA sequence databases: status for the year 2000," Nucl. Acids Res. 28:292 (2000).
  • Codon usage tables for yeast calculated from GenBank Release 128.0 [15 February 2002], are reproduced below as Table 2.
  • This table uses mRNA nomenclature, and so instead of thymine (T) which is found in DNA, the tables use uracil (U) which is found in RNA.
  • T thymine
  • U uracil
  • the Table has been adapted so that frequencies are calculated for each amino acid, rather than for all 64 codons.
  • Codon-optimized coding regions can be designed by various different methods.
  • a codon usage table is used to find the single most frequent codon used for any given amino acid, and that codon is used each time that particular amino acid appears in the polypeptide sequence. For example, referring to Table 2 above, for leucine, the most frequent codon is UUG, which is used 27.2% of the time. Thus all the leucine residues in a given amino acid sequence would be assigned the codon UUG.
  • the actual frequencies of the codons are distributed randomly throughout the coding sequence.
  • a hypothetical polypeptide sequence had 100 leucine residues, referring to Table 2 for frequency of usage in the S. cerevisiae, about 5, or 5% of the leucine codons would be CUC, about 11, or 11% of the leucine codons would be CUG, about 12, or 12% of the leucine codons would be CUU, about 13, or 13% of the leucine codons would be CUA, about 26, or 26% of the leucine codons would be UUA, and about 27, or 27% of the leucine codons would be UUG.
  • the fractional frequency of codon usage would be calculated by multiplying 62 by the frequencies for the various codons.
  • 7.28 percent of 62 equals 4.51 UUA codons, or "about 5," i.e., 4, 5, or 6 UUA codons
  • 12.66 percent of 62 equals 7.85 UUG codons or "about 8,” i.e., 7, 8, or 9 UUG codons
  • 12.87 percent of 62 equals 7.98 CUU codons, or "about 8," i.e., 7, 8, or 9 CUU codons
  • 19.56 percent of 62 equals 12.13 CUC codons or "about 12," i.e.
  • Randomly assigning codons at an optimized frequency to encode a given polypeptide sequence can be done manually by calculating codon frequencies for each amino acid, and then assigning the codons to the polypeptide sequence randomly.
  • various algorithms and computer software programs are readily available to those of ordinary skill in the art. For example, the "EditSeq” function in the Lasergene Package, available from DNAstar, Inc., Madison, WI, the backtranslation function in the VectorNTI Suite, available from InforMax, Inc., Bethesda, MD, and the "backtranslate” function in the GCG ⁇ Wisconsin Package, available from Accelrys, Inc., San Diego, CA.
  • oligonucleotide pairs are synthesized such that upon annealing, they form double stranded fragments of 80-90 base pairs, containing cohesive ends, e.g., each oligonucleotide in the pair is synthesized to extend 3, 4, 5, 6, 7, 8, 9, 10, or more bases beyond the region that is complementary to the other oligonucleotide in the pair.
  • the single-stranded ends of each pair of oligonucleotides is designed to anneal with the single-stranded end of another pair of oligonucleotides.
  • the oligonucleotide pairs are allowed to anneal, and approximately five to six of these double-stranded fragments are then allowed to anneal together via the cohesive single stranded ends, and then they ligated together and cloned into a standard bacterial cloning vector, for example, a TOPO ® vector available from Invitrogen Corporation, Carlsbad, CA.
  • the construct is then sequenced by standard methods. Several of these constructs consisting of 5 to 6 fragments of 80 to 90 base pair fragments ligated together, i.e., fragments of about 500 base pairs, are prepared, such that the entire desired sequence is represented in a series of plasmid constructs.
  • the inserts of these plasmids are then cut with appropriate restriction enzymes and ligated together to form the final construct.
  • the final construct is then cloned into a standard bacterial cloning vector, and sequenced. Additional methods would be immediately apparent to the skilled artisan. In addition, gene synthesis is readily available commercially.
  • a full-length polypeptide sequence is codon-optimized for a given species resulting in a codon-optimized coding region encoding the entire polypeptide, and then nucleic acid fragments of the codon-optimized coding region, which encode fragments, variants, and derivatives of the polypeptide are made from the original codon-optimized coding region.
  • nucleic acid fragments encoding fragments, variants, and derivatives would not necessarily be fully codon optimized for the given species.
  • host cells for use in the invention are genetically engineered
  • the vectors of this invention may be, for example, a cloning vector or an expression vector.
  • the vector may be, for example, in the form of a plasmid, a viral particle, a phage, etc.
  • the engineered host cells can be cultured in conventional nutrient media modified as appropriate for activating promoters, selecting transformants or amplifying the genes of the present invention.
  • the culture conditions such as temperature, pH and the like, are those previously used with the host cell selected for expression, and will be apparent to the ordinarily skilled artisan.
  • Polynucleotides can be employed for producing polypeptides by recombinant techniques.
  • the polynucleotide can be included in any one of a variety of expression vectors for expressing a polypeptide.
  • Such vectors include chromosomal, nonchromosomal and synthetic DNA sequences, e.g., derivatives of SV40; bacterial plasmids; and yeast plasmids.
  • any other vector can be used, as long as it is replicable and viable in the host.
  • the appropriate DNA sequence may be inserted into the vector by a variety of procedures.
  • the DNA sequence is inserted into an appropriate restriction endonuclease site(s) by procedures known in the art. Such procedures and others are deemed to be within the scope of those skilled in the art.
  • the DNA sequence in the expression vector is operatively associated with an appropriate expression control sequence(s) (promoter) to direct mRNA synthesis.
  • promoter an appropriate expression control sequence(s) to direct mRNA synthesis.
  • promoters are as follows:
  • promoter sequences from stress and starvation response genes are useful in the present invention.
  • ATG11, ATG12, ATG13, ATG14, ATG15, ATG16, ATGI 7, ATGI8, and ATGI9 may be used. Any suitable promoter to drive gene expression in the host cells of the invention may be used. Additionally the E. coli, lac or trp, and other promoters known to control expression of genes in prokaryotic or lower eukaryotic cells can be used.
  • the expression vectors may contain one or more selectable marker genes to provide a phenotypic trait for selection of transformed host cells such as URA3, HIS3, LEU2, TRPI, LYS2 or ADE 2, dihydrofolate reductase, neomycin (G418) resistance or zeocin resistance for eukaryotic cell culture, or tetracycline or ampicillin resistance in E. coli.
  • the expression vector may also contain a ribosome binding site for translation initiation and/or a transcription terminator.
  • the vector may also include appropriate sequences for amplifying expression, or may include additional regulatory regions.
  • the vector containing the appropriate DNA sequence as herein, as well as an appropriate promoter or control sequence, may be employed to transform an appropriate host to permit the host to express the protein.
  • host cells for use in the invention contain the above- described constructs.
  • the host cell can be a host cell as described elsewhere in the application.
  • the host cell can be, for example, a lower eukaryotic cell, such as a yeast cell, e.g., Saccharomyces cerevisiae or Kluyveromyces, or the host cell can be a prokaryotic cell, such as a bacterial cell.
  • bacterial cells such as E. coli, Streptomyces, Salmonella typhimurium
  • thermophilic or mesophlic bacteria fungal cells, such as yeast
  • fungal cells such as yeast
  • plant cells etc.
  • the selection of an appropriate host is deemed to be within the scope of those skilled in the art from the teachings herein.
  • Appropriate fungal hosts include yeast.
  • the yeast is selected from the group consisting of Saccharomyces cerevisiae, Kluyveromyces lactis, Schizzosaccharomyces pombe, Candida albicans, Pichia pastoris, Pichia stipitis, Yarrowia lipolytica, Hansenula polymorpha, Phaffia rhodozyma, Candida utilis, Arxula adeninivorans, Debaryomyces hansenii, Debaryomyces polymorphus, Schwanniomyces occidentalis, Issatchenkia orientalis, Kluyveromyces marxianus, Blakeslea, Candida, Cryptococcus, Cunninghamella, Lipomyces, Mortierella, Mucor, Phycomces, Pythium, Rhodosporidium, Rhodotorula, Trichosporon and Yarrowia
  • plasmids there are two processes by which this can occur. One is through the use of replicative plasmids. These plasmids have origins of replication that are recognized by the host and allow the plasmids to replicate as stable, autonomous, extrachromosomal elements that are partitioned during cell division into daughter cells. The second process occurs through the integration of a plasmid onto the chromosome. This predominately happens by homologous recombination and results in the insertion of the entire plasmid, or parts of the plasmid, into the host chromosome.
  • the plasmid and selectable marker(s) are replicated as an integral piece of the chromosome and segregated into daughter cells. Therefore, to ascertain if plasmid DNA is entering a cell during a transformation event through the use of selectable markers requires the use of a replicative plasmid or the ability to recombine the plasmid onto the chromosome. These qualifiers cannot always be met, especially when handling organisms that do not have a suite of genetic tools.
  • transposase is a mobile DNA element, defined by mosaic DNA sequences that are recognized by enzymatic machinery referred to as a transposase.
  • the function of the transposase is to randomly insert the transposon DNA into host or target DNA.
  • a selectable marker can be cloned onto a transposon by standard genetic engineering. The resulting DNA fragment can be coupled to the transposase machinery in an in vitro reaction and the complex can be introduced into target cells by electroporation. Stable insertion of the marker onto the chromosome requires only the function of the transposase machinery and alleviates the need for homologous recombination or replicative plasmids.
  • transposons has the added advantage of acting as a form of mutagenesis.
  • Libraries can be created that comprise amalgamations of transposon mutants. These libraries can be used in screens or selections to produce mutants with desired phenotypes. For instance, a transposon library of a CBP organism could be screened for the ability to produce less ethanol, or more lactic acid and/or more acetate.
  • Naturally occurring cellulolytic microorganisms are starting points for CBP organism development via the native strategy.
  • Anaerobes and facultative anaerobes are of particular interest.
  • the primary objective is to engineer product yields and lactate or acetate titers to satisfy the requirements of an industrial process.
  • Metabolic engineering of mixed-acid fermentations in relation to, for example, ethanol production has been successful in the case of mesophilic, non-cellulolytic, enteric bacteria.
  • Recent developments in suitable gene -transfer techniques allow for this type of work to be undertaken with cellulolytic bacteria.
  • Non-cellulolytic microorganisms with desired product- formation properties are starting points for CBP organism development by the recombinant cellulolytic strategy.
  • the primary objective of such developments is to engineer a heterologous cellulase system that enables growth and fermentation on pretreated lignocellulose.
  • the heterologous production of cellulases has been pursued primarily with bacterial hosts producing ethanol at high yield (engineered strains of E. coli, Klebsiella oxytoca, and Zymomonas mobilis) and the yeast Saccharomyces cerevisiae. Cellulase expression in strains of K.
  • thermophilic or mesophilic microorganisms as hosts for modification via the native cellulolytic strategy. Their potential in process applications in biotechnology stems from their ability to grow at relatively high temperatures with attendant high metabolic rates, production of physically and chemically stable enzymes, and elevated yields of end products.
  • thermophilic bacteria include eubacteria and archaebacteria.
  • Thermophilic eubacteria include: phototropic bacteria, such as cyanobacteria, purple bacteria, and green bacteria; Gram-positive bacteria, such as Bacillus, Clostridium, Lactic acid bacteria, and Actinomyces; and other eubacteria, such as Thiobacillus, Spirochete, Desulfotomaculum, Gram-negative aerobes, Gram-negative anaerobes, and Thermotoga.
  • Archaebacteria are considered Methanogens, extreme thermophiles (an art-recognized term), and Thermoplasma.
  • the present invention relates to Gram-negative organotrophic thermophiles of the genera Thermus, Gram-positive eubacteria, such as genera Clostridium, and also which comprise both rods and cocci, genera in group of eubacteria, such as Thermosipho and Thermotoga, genera of Archaebacteria, such as Thermococcus, Thermoproteus (rod-shaped), Thermofilum (rod- shaped), Pyrodictium, Acidianus, Sulfolobus, Pyrobaculum, Pyrococcus, Thermodiscus, Staphylothermus, Desulfurococcus, Archaeoglobus, and Methanopyrus.
  • thermophilic or mesophilic including bacteria, procaryotic microorganism, and fungi
  • thermophilic or mesophilic include, but are not limited to: Clostridium thermosulfurogenes, Clostridium cellulolyticum, Clostridium thermocellum, Clostridium thermohydrosulfuricum, Clostridium thermoaceticum, Clostridium thermosaccharolyticum, Clostridium tartarivorum, Clostridium thermocellulaseum, Clostridium phytofermentans, Clostridium straminosolvens, Thermoanaerobacterium thermosaccarolyticum, Thermoanaerobacterium saccharolyticum, Thermobacteroides acetoethylicus, Thermoanaerobium brockii, Methanobacterium thermoautotrophicum, Anaerocellum thermophilium, Pyrodictium occultum, Thermoproteus neutr
  • thermophilic bacteria selected from the group consisting of Clostridium cellulolyticum, Clostridium thermocellum, and Thermoanaerobacterium saccharolyticum.
  • thermophilic bacteria selected from the group consisting of Fervidobacterium gondwanense, Clostridium thermolacticum, Moorella sp., and Rhodothermus marinus.
  • the present invention relates to thermophilic bacteria of the genera Thermoanaerobacterium or Thermoanaerobacter, including, but not limited to, species selected from the group consisting of: Thermoanaerobacterium thermosulfurigenes, Thermoanaerobacterium aotearoense, Thermoanaerobacterium polysaccharolyticum, Thermoanaerobacterium zeae, Thermoanaerobacterium xylanolyticum, Thermoanaerobacterium saccharolyticum, Thermoanaerobium brockii, Thermoanaerobacterium thermosaccharolyticum, Thermoanaerobacter thermohydrosulfuricus, Thermoanaerobacter ethanolicus, Thermoanaerobacter brockii, variants thereof, and progeny thereof.
  • the present invention relates to microorganisms of the genera Geobacillus, Saccharococcus, Paenibacillus, Bacillus, and Anoxybacillus, including, but not limited to, species selected from the group consisting of: Geobacillus thermoglucosidasius, Geobacillus stearothermophilus, Saccharococcus caldoxylosilyticus, Saccharococcus thermophilus, Paenibacillus campinasensis, Bacillus flavothermus, Anoxybacillus kamchatkensis, Anoxybacillus gonensis, variants thereof, and progeny thereof.
  • species selected from the group consisting of: Geobacillus thermoglucosidasius, Geobacillus stearothermophilus, Saccharococcus caldoxylosilyticus, Saccharococcus thermophilus, Paenibacillus campinasensis, Bacillus flavothermus, Anoxybacillus kamchatkensis, Anoxybacillus gone
  • the present invention relates to mesophilic bacteria selected from the group consisting of Saccharophagus degradans; Flavobacterium johnsoniae; Fibrobacter succinogenes; Clostridium hungatei; Clostridium phytofermentans; Clostridium cellulolyticum; Clostridium aldrichii; Clostridium termitididis; Acetivibrio cellulolyticus; Acetivibrio ethanolgignens; Acetivibrio multivorans; Bacteroides cellulosolvens; and Alkalibacter saccharofomentans, variants thereof and progeny thereof.
  • a population of microorganisms can be used to produce ethanol from cellulosic substrates and a sugar stream. Such methods can be accomplished, for example, by contacting a cellulosic substrate and a sugar stream with a host cell or a co-culture as known in the art and/or as described herein.
  • Sugar streams for use in the invention include sugars derived from a natural source including, but not limited to molasses, cane juice, or starch ⁇ e.g., potato, wheat, or corn). Sugar streams may be available at an existing fermentation facility, to which cellulosic substrates are added ⁇ e.g., pretreated lignocellulosic biomass). The fermentation facility may use either a wet milling or a dry milling process.
  • Numerous cellulosic substrates can be used in accordance with the present invention. Substrates for cellulose activity assays can be divided into two categories, soluble and insoluble, based on their solubility in water.
  • Soluble substrates include cellodextrins or derivatives, carboxymethyl cellulose (CMC), or hydroxyethyl cellulose (HEC).
  • Insoluble substrates include crystalline cellulose, micro crystalline cellulose (Avicel), amorphous cellulose, such as phosphoric acid swollen cellulose (PASC), dyed or fluorescent cellulose, and pretreated lignocellulosic biomass. These substrates are generally highly ordered cellulosic material and thus only sparingly soluble.
  • suitable lignocellulosic material may be any feedstock that contains soluble and/or insoluble cellulose, where the insoluble cellulose may be in a crystalline or non-crystalline form.
  • the lignocellulosic biomass comprises, for example, wood, corn, corn stover, sawdust, bark, leaves, agricultural and forestry residues, grasses such as switchgrass, ruminant digestion products, municipal wastes, paper mill effluent, newspaper, cardboard or combinations thereof.
  • the invention is directed to a method for hydrolyzing a cellulosic substrate, for example a cellulosic substrate as described above, by contacting the cellulosic substrate with a host cell of the invention.
  • the invention is directed to a method for hydrolyzing a cellulosic substrate, for example a cellulosic substrate as described above, by contacting the cellulosic substrate with a co- culture comprising yeast cells expressing heterologous cellulases.
  • the invention is directed to a method for fermenting cellulose. Such methods can be accomplished, for example, by culturing a host cell or co- culture in a medium that contains insoluble cellulose to allow saccharification and fermentation of the cellulose.
  • the production of ethanol can, according to the present invention, be performed at temperatures of at least about 30° C, about 31° C, about 32° C, about 33° C, about 34° C, about 35° C, about 36° C, about 37° C, about 38° C, about 39° C, about 40° C, about 41° C, about 42° C, about 43 °C, about 44 °C, about 45 °C, about 46 °C, about 47 °C, about 48 °C, about 49 °C, or about 50° C.
  • thermotolerant host cell can produce ethanol from cellulose at temperatures above about 30° C, about 31° C, about 32° C, about 33° C, about 34° C, about 35° C, about 36° C, about 37° C, about 38° C, about 39° C, about 40° C, about 41° C, about 42° C, or about 43 °C, or about 44 °C, or about 45 °C, or about 50° C.
  • thermotolterant host cell can produce ethanol from cellulose at temperatures from about 30° C to 60° C, about 30° C to 55° C, about 30° C to 50° C, about 40° C to 60° C, about 40° C to 55° C or about 40° C to 50° C.
  • microorganisms are known to be useful for the conversion of organic material to ethanol.
  • examples of microorganisms which may be used in practice are fermentation agents, such as Saccharomyces cerevisiae for producing ethanol.
  • An alternative ethanol-producing organism which may be used is Zymomonas mobilis or a member selected from the Zymomonas, Erwinia, Klebsiella, Xanthomonas or Escherichia genii.
  • Other microorganisms that convert sugars to ethanol include species of Schizosaccharomyces (such as S. pombe), Pichia (P. stipitis), Candida (C. shehatae) and Pachysolen (P. tannophilus).
  • the microorganisms of the subject invention can also be engineered with nucleic acids, such as those disclosed in U.S. Pat. No. 5,000,000, which is hereby incorporated by reference.
  • the d-ldh, 1-ldh, ppc, ack, pfl genes of said microorganisms may optionally be inactivated.
  • genes coding for the alcohol dehydrogenase II and pyruvate decarboxylase activities together with appropriate regulatory sequences may be used to transform host cells; the regulatory sequences may consist of promoters, inducers, operators, ribosomal binding sites, terminators, and/or other regulatory sequences. See U.S. Patent No.
  • a biocatalyst such as a recombinant ethanologenic bacterium, can be engineered to express one or more enzymatic activities, such as those described above, in particular amounts sufficient for degrading complex sugars. Such a biocatalyst would be suitable for the efficient degradation of complex sugars and subsequent fermentation into alcohol in the processes of the present invention.
  • Ethanol production can be measured using any method known in the art.
  • the quantity of ethanol in fermentation samples can be assessed using HPLC analysis.
  • Many ethanol assay kits are commercially available that use, for example, alcohol oxidase enzyme based assays. Methods of determining ethanol production are within the scope of those skilled in the art from the teachings herein.
  • the U.S. Department of Energy (DOE) provides a method for calculating theoretical ethanol yield. Accordingly, if the weight percentages are known of C6 sugars (i.e., glucan, galactan, mannan), the theoretical yield of ethanol in gallons per dry ton of total C6 polymers can be determined by applying a conversion factor as follows:
  • the DOE provides the following examples of theoretical yield of ethanol in gallons per dry ton of feedstock: corn grain, 124.4; corn stover, 113.0; rice straw, 109.9; cotton gin trash, 56.8; forest thinnings, 81.5; hardwood sawdust, 100.8; bagasse, 111.5; and mixed paper, 116.2. It is important to note that these are theoretical yields.
  • the DOE warns that depending on the nature of the feedstock and the process employed, actual yield could be anywhere from 60% to 90% of theoretical, and further states that "achieving high yield may be costly, however, so lower yield processes may often be more cost effective.” ⁇ Ibid.)
  • aspects of the present invention relate to improvements in process economics without sacrificing foreseeable ethanol yield. Because cheaper construction materials may be used, pretreatment capital costs are reduced considerably if severe conditions are not required. This approach does not reduce the ethanol yield because it achieves the same the results associated with acidic high and/or temperature pretreatment. It is recognized that without aggressive pretreatment conditions, fractional separation of the biomass may not be complete. Nevertheless, high enzyme loading at temperatures of optimal enzymatic activity may still enable complete hemicellulose hydrolysis and an ethanol yield comparable or greater than what could be achieved with high temperature or acidic pretreatment. Said high enzyme loading is feasible because the enzyme is not purchased.
  • the invention is directed to a method for the production of a fermentation product, the method comprising: i) contacting a pretreated lignocellulosic biomass feedstock, a sugar stream, and a population of microorganisms capable of hydrolyzing the lignocellulosic biomass and fermenting sugars into a fermentation product; and ii) culturing said population of microorganisms under conditions for a period sufficient to allow hydrolysis of the lignocellulosic biomass and fermentation of sugars by said population of microorganisms into a fermentation product.
  • exogenous enzymes are added to the culture.
  • the lignocellulosic biomass feedstock is selected from the group consisting of: grass, switch grass, cord grass, rye grass, reed canary grass, miscanthus, sugar-processing residues, sugarcane bagasse, agricultural wastes, rice straw, rice hulls, barley straw, corn cobs, cereal straw, wheat straw, canola straw, oat straw, oat hulls, corn fiber, stover, soybean stover, corn stover, forestry wastes, recycled wood pulp fiber, paper sludge, sawdust, hardwood, softwood, Agave, and combinations thereof.
  • the sugar stream is selected from the group consisting of: molasses, sugar cane, sugar beet, corn starch, wheat starch, and potato starch.
  • the sugar stream is provided by a dry milling process. In another embodiment, the sugar stream is provided by a wet milling process.
  • the population of microorganisms is selected from the group consisting of bacteria and yeast. In one embodiment, the population of microorganisms comprises at least one genetically modified microorganism. In a specific embodiment, the genetically modified microorganism is a bacterium. In a more specific embodiment, the bacterium is thermophilic or mesophilic. In another embodiment, the genetically modified microorganism is a fungus. In a more specific embodiment, the fungus is a yeast.
  • the fermentation product is selected from the group consisting of an alcohol, lactic acid, and acetic acid.
  • the fermentation product is ethanol.
  • Pretreated solids are diluted with at least one sugar stream, for example, cane juice, molasses, sugar beet juice, or hydrolyzed starch.
  • sugar streams are available from corn processing in either dry mill or wet mill configurations. Performance is expected to improve markedly because of two compounding factors: 1) reduced concentrations of inhibitors of cellulase synthesis and function and 2) increased cellulase loading (g cellulase protein/g cellulose). The latter arises because microorganisms synthesize cellulases from added sugar-rich streams as well as from cellulose.
  • reference process configuration "A” operating at 25 wt. % solids without sugar dilution, presents conditions under which rate and yield is compromised due to inhibition of cellulase synthesis and cellulase function, and mixing is challenging.
  • the cellulose concentration is about 15 wt. %.
  • the ethanol concentration is 5.06 wt.%.
  • Reference process configuration "B” features dilution by a stream containing soluble sugar at a concentration of 15 wt.% (readily available in existing industrial plants mentioned above) blended with pretreated solids at a ratio of, for example, 2:3, (for purpose of illustration—other ratios could be established).
  • Excess cellulase- producing microorganisms could be added to pretreated cellulosic biomass, with or without dilution as above. Such addition could allow higher loading of cellulase and cells per unit pretreated biomass than could be achieved via CBP in which cell and cellulase synthesis occurred primarily or entirely in the CBP reactor.
  • CBP cell and cellulase synthesis occurred primarily or entirely in the CBP reactor.
  • One of ordinary skill in the art is aware that performance would improve markedly at high cellulase and cell loadings. Performance is particularly improved if cellulases are expressed on the cell surface, which fosters co-recovery of cellulase when cells are harvested following soluble sugar fermentation.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne des procédés pour la production d'un produit de fermentation comprenant la co-fermentation d'un courant de sucre avec une biomasse lignocellulosique prétraitée. Des charges d'alimentation de biomasse lignocellulosique utiles dans les procédés comprennent une graminée, le panic raid, la spartine pectinée, l'ivraie, l'alpiste roseau, le miscanthus commun, les résidus de traitement de sucre, la bagasse de sucre de canne, les déchets agricoles, la paille de riz, la balle de riz, la paille d'orge, la rafle de maïs, la paille céréalière, la paille de blé, la paille de colza canola, la paille d'avoine, l'écale d'avoine, la fibre de maïs, le fourrage, la canne de soja, la canne de maïs, les déchets forestiers, la fibre de pâte de bois recyclée, la boue de papier, la sciure, le bois dur, le bois doux, l'agave et leurs combinaisons. Les courants de sucre utiles dans les procédés comprennent les molasses, la canne à sucre, la betterave à sucre, la fécule de maïs, l'amidon de blé et la fécule de pomme de terre. Les produits de fermentation comprennent les alcools (comprenant, par exemple, l'éthanol), l'acide lactique et l'acide acétique. Les procédés peuvent être effectués à des installations de fermentation existantes, qui augmenteront le rendement des produits de fermentation et réduiront les coûts de production.
PCT/US2014/026499 2013-03-14 2014-03-13 Co-conversion de glucides en produits de fermentation dans une étape de fermentation unique WO2014160402A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361783138P 2013-03-14 2013-03-14
US61/783,138 2013-03-14

Publications (1)

Publication Number Publication Date
WO2014160402A1 true WO2014160402A1 (fr) 2014-10-02

Family

ID=50771571

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/026499 WO2014160402A1 (fr) 2013-03-14 2014-03-13 Co-conversion de glucides en produits de fermentation dans une étape de fermentation unique

Country Status (1)

Country Link
WO (1) WO2014160402A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107190552A (zh) * 2017-07-15 2017-09-22 齐永怡 利用麦草和蔗渣制造纸张的方法
CN108823102A (zh) * 2018-06-10 2018-11-16 东北农业大学 寒地秸秆腐熟真菌被孢霉菌株及其在水稻秸秆腐熟中的应用
US10920247B2 (en) 2017-09-05 2021-02-16 Poet Research, Inc. Methods and systems for propagation of a microorganism using a pulp mill and/or a paper mill waste by-product, and related methods and systems
US11753656B2 (en) 2013-08-15 2023-09-12 Lallemand Hungary Liquidity Management Llc Methods for the improvement of product yield and production in a microorganism through glycerol recycling

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5000000A (en) 1988-08-31 1991-03-19 University Of Florida Ethanol production by Escherichia coli strains co-expressing Zymomonas PDC and ADH genes
US5821093A (en) 1988-08-31 1998-10-13 University Of Florida Research Foundation, Inc. Recombinant cells that highly express chromosomally-integrated heterologous genes
WO1998045425A1 (fr) 1997-04-07 1998-10-15 University Of Florida Research Foundation, Inc. Obtention d'escherichia coli resistantes a l'ethanol hautement concentre
US6333181B1 (en) 1997-04-07 2001-12-25 University Of Florida Research Foundation, Inc. Ethanol production from lignocellulose
WO2006009434A1 (fr) 2004-07-16 2006-01-26 Technische Universiteit Delft Genie metabolique de cellules eucaryotes de fermentation du xylose
US7026152B2 (en) 2000-06-26 2006-04-11 University Of Florida Research Foundation, Inc. Methods and compositions for simultaneous saccharification and fermentation
US7098009B2 (en) 2004-03-04 2006-08-29 University Of Florida Research Foundation, Inc. Production of chemicals from lignocellulose, biomass or sugars
WO2009015481A1 (fr) * 2007-08-02 2009-02-05 Iogen Energy Corporation Procédé faisant appel à des enzymes cellulases pour produire de l'alcool et du glucose à partir d'une charge lignocellulosiques prétraitée
WO2012066042A1 (fr) * 2010-11-17 2012-05-24 Sekab E-Technology Ab Mesures dans le pir dans la production d'un agent chimique cible à partir de cellulose
WO2014074895A2 (fr) * 2012-11-09 2014-05-15 Mascoma Corporation Procédé pour la consommation d'acétate pendant la fermentation éthanolique de charges d'alimentation cellulosiques

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5000000A (en) 1988-08-31 1991-03-19 University Of Florida Ethanol production by Escherichia coli strains co-expressing Zymomonas PDC and ADH genes
US5821093A (en) 1988-08-31 1998-10-13 University Of Florida Research Foundation, Inc. Recombinant cells that highly express chromosomally-integrated heterologous genes
WO1998045425A1 (fr) 1997-04-07 1998-10-15 University Of Florida Research Foundation, Inc. Obtention d'escherichia coli resistantes a l'ethanol hautement concentre
US6333181B1 (en) 1997-04-07 2001-12-25 University Of Florida Research Foundation, Inc. Ethanol production from lignocellulose
US7026152B2 (en) 2000-06-26 2006-04-11 University Of Florida Research Foundation, Inc. Methods and compositions for simultaneous saccharification and fermentation
US7098009B2 (en) 2004-03-04 2006-08-29 University Of Florida Research Foundation, Inc. Production of chemicals from lignocellulose, biomass or sugars
WO2006009434A1 (fr) 2004-07-16 2006-01-26 Technische Universiteit Delft Genie metabolique de cellules eucaryotes de fermentation du xylose
WO2009015481A1 (fr) * 2007-08-02 2009-02-05 Iogen Energy Corporation Procédé faisant appel à des enzymes cellulases pour produire de l'alcool et du glucose à partir d'une charge lignocellulosiques prétraitée
WO2012066042A1 (fr) * 2010-11-17 2012-05-24 Sekab E-Technology Ab Mesures dans le pir dans la production d'un agent chimique cible à partir de cellulose
WO2014074895A2 (fr) * 2012-11-09 2014-05-15 Mascoma Corporation Procédé pour la consommation d'acétate pendant la fermentation éthanolique de charges d'alimentation cellulosiques

Non-Patent Citations (28)

* Cited by examiner, † Cited by third party
Title
"Current Protocols in Molecular Biology", 1992, JOHN WILEY & SONS
"Genes II", 1985, JOHN WILEY & SONS
"Ultimate low-cost configuration for cellulose hydrolysis and fermentation", DOE/USA JOINT RESEARCH AGENDA
BOWIE ET AL.: "Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions", SCIENCE, vol. 247, 1990, pages 1306 - 1310, XP002939052, DOI: doi:10.1126/science.2315699
BREAKING THE BIOLOGICAL BARRIERS TO CELLULOSIC ETHANOL: A JOINT RESEARCH AGENDA, December 2005 (2005-12-01)
BRETHAUER S ET AL: "Review: Continuous hydrolysis and fermentation for cellulosic ethanol production", BIORESOURCE TECHNOLOGY, ELSEVIER BV, GB, vol. 101, no. 13, 1 July 2010 (2010-07-01), pages 4862 - 4874, XP026986220, ISSN: 0960-8524, [retrieved on 20100327] *
CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085
CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, pages 13.7.1 - 13.7.10
DAVIS, L. ET AL., BASIC METHODS IN MOLECULAR BIOLOGY, 1986
DESAI ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 65, 2004, pages 600
DOE/SC-0095 JOINT RESEARCH AGENDA
JEPPSSON ET AL., APPL. ENVIRON. MICROBIOL., vol. 68, no. 4, April 2002 (2002-04-01), pages 1604 - 9
KARHUMAA ET AL., MICROB. CELL. FACT., vol. 6, 5 February 2007 (2007-02-05), pages 5
KREIG ET AL.: "Bergey's Manual of Determžnatžve Bacteriology", 1984, WILLIAMS AND WILKINS
KUYPER, M. ET AL., FEMS YEAST RES., vol. 4, 2004, pages 655 - 64
KUYPER, M. ET AL., FEMS YEAST RES., vol. 5, 2005, pages 399 - 409
KUYPER, M. ET AL., FEMS YEAST RES., vol. 5, 2005, pages 925 - 34
LEE J M ET AL: "Detoxification of woody hydrolyzates with activated carbon for bioconversion to ethanol by the thermophilic anaerobic bacterium Thermoanaerobacterium saccharolyticum", BIOMASS AND BIOENERGY, PERGAMON, AMSTERDAM, NL, vol. 35, no. 1, 1 January 2011 (2011-01-01), pages 626 - 636, XP027577878, ISSN: 0961-9534, [retrieved on 20101228], DOI: 10.1016/J.BIOMBIOE.2010.10.021 *
LYND ET AL., MICROBIOL. MOL. BIOL. REV., vol. 66, 2002, pages 506
LYND ET AL.: "Consolidated bioprocessing of cellulosic biomass: An update", CURRENT OPINION IN BIOTECHNOLOGY, vol. 16, no. 5, 2005, pages 577 - 583, XP005097204, DOI: doi:10.1016/j.copbio.2005.08.009
LYND ET AL.: "Microbial cellulose utilization: Fundamentals and biotechnology", MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, vol. 66, no. 3, 2002, pages 506 - 577, XP002551605, DOI: doi:10.1128/MMBR.66.3.506-577.2002
MCLAUGHLIN ET AL., ENVIRON. SCI. TECHNOL., vol. 36, 2002, pages 2122
MCMILLAN J D ED - SHALABY SHALABY W: "CONVERSION OF HEMICELLULOSE HYDROLYZATES TO ETHANOL", WATER-SOLUBLE POLYMERS: SYNTHESIS, SOLUTION PROPERTIES AND APPLICATIONS, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 566, 1 January 1994 (1994-01-01), pages 411 - 437, XP008045627, ISBN: 978-0-541-23408-9 *
NAKAMURA, Y. ET AL.: "Codon usage tabulated from the international DNA sequence databases: status for the year 2000", NUCL. ACIDS RES., vol. 28, 2000, pages 292, XP002941557, DOI: doi:10.1093/nar/28.1.292
SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual.", 1989, COLD SPRING HARBOR LABORATORY PRESS
SAMBROOK, J.; FRITSCH, E. F.; MANIATIS, T.: "MOLECULAR CLONING: A LABORATORY MANUAL", 1989, COLD SPRING HARBOR LABORATORY PRESS
VAN WALSUM; LYND, BIOTECH. BIOENG., vol. 58, 1998, pages 316
YOMANO ET AL., J IND. MICRO. & BIO., vol. 20, 1998, pages 132 - 138

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11753656B2 (en) 2013-08-15 2023-09-12 Lallemand Hungary Liquidity Management Llc Methods for the improvement of product yield and production in a microorganism through glycerol recycling
CN107190552A (zh) * 2017-07-15 2017-09-22 齐永怡 利用麦草和蔗渣制造纸张的方法
US10920247B2 (en) 2017-09-05 2021-02-16 Poet Research, Inc. Methods and systems for propagation of a microorganism using a pulp mill and/or a paper mill waste by-product, and related methods and systems
CN108823102A (zh) * 2018-06-10 2018-11-16 东北农业大学 寒地秸秆腐熟真菌被孢霉菌株及其在水稻秸秆腐熟中的应用

Similar Documents

Publication Publication Date Title
US20230159962A1 (en) Recombinant yeast expressing heterologous stl1 protein
US20220098600A1 (en) Methods for the improvement of product yield and production in a microorganism through the addition of alternate electron acceptors
AU2009316309B2 (en) Yeast expressing cellulases for simultaneous saccharification and fermentation using cellulose
US10047380B2 (en) Genetically modified strain of S. cerevisiae engineered to ferment xylose and arabinose
CA2798452C (fr) Detoxification d'acetate derive de biomasse par conversion metabolique en ethanol, acetone, isopropanol ou acetate d'ethyle
CA2881772C (fr) Expression d'enzymes dans une levure pour biotraitement consolide d'oligomeres derives de lignocellulose
EP3168300A1 (fr) Levure exprimant des enzymes saccharolytiques pour bio-processus consolide a l'aide d'amidon et de cellulose
US20110312054A1 (en) Isolation and Characterization of Schizochytrium Aggregatum Cellobiohydrolase I (CBH I)
CA2822654A1 (fr) Clostridium thermocellum genetiquement modifie pour fermenter le xylose
WO2014160402A1 (fr) Co-conversion de glucides en produits de fermentation dans une étape de fermentation unique
WO2019175809A1 (fr) Levure et produit de levure inactivés pour améliorer le rendement de fermentation
US20220090045A1 (en) Methods for producing isopropanol and acetone in a microorganism
WO2023170628A1 (fr) Alpha-amylases bacteriennes et archaéales
BR112016002359B1 (pt) Microorganismo recombinate, método para diminuir o glicerol celular produzido, e processo para a conversão de biomassa em etanol

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14725808

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14725808

Country of ref document: EP

Kind code of ref document: A1